@NP	Schwann Cell	1
@NP	Ensheathing Glia Transplants	32
@NP	Hindlimb Locomotor Performance in the Moderately Contused Adult Rat	69
@NP	Hindlimb Locomotor Performance	69
@NP	the Moderately Contused Adult Rat	103
@NP	Thoracic Spinal Cord Toshihiro Takami ,1 Martin Oudega ,1,2 Margaret L.	137
@NP	Thoracic Spinal Cord Toshihiro Takami ,1 Martin	137
@NP	Oudega ,1,2 Margaret L.	185
@NP	Bates ,1 Patrick M.	208
@NP	Bates ,1	208
@NP	Patrick M.	216
@NP	Wood ,1,2 Naomi Kleitman ,1,2	227
@NP	Wood ,1,2 Naomi Kleitman	227
@NP	,1,2	250
@NP	Mary Bartlett Bunge1 ,2,3 1The	259
@NP	Chambers Family Laboratory of Electron Microscopy , The Miami Project	289
@NP	Chambers Family Laboratory	289
@NP	Electron Microscopy , The Miami Project	319
@NP	Electron Microscopy	319
@NP	The Miami Project	340
@NP	Paralysis	366
@NP	the Departments	381
@NP	2Neurological Surgery and 3Cell Biology and Anatomy , University	400
@NP	Miami School	467
@NP	Medicine , Miami , Florida 33136	483
@NP	adult rat Schwann cells -LRB- SCs -RRB-	524
@NP	adult rat Schwann cells	524
@NP	SCs	549
@NP	olfactory ensheathing glia -LRB- OEG -RRB-	557
@NP	olfactory ensheathing glia	557
@NP	OEG	585
@NP	both	594
@NP	the adult Fischer rat	621
@NP	thoracic -LRB- T9 -RRB- spinal cord 1 week	643
@NP	thoracic -LRB- T9 -RRB- spinal cord	643
@NP	1 week	669
@NP	a moderate contusion -LRB- 10 gm , 12.5 mm , NYU impactor -RRB-	682
@NP	a moderate contusion	682
@NP	10 gm	704
@NP	12.5 mm	711
@NP	NYU impactor	720
@NP	Rats	735
@NP	a total	756
@NP	2 106 cells	767
@NP	culture medium or culture medium only -LRB- controls -RRB-	794
@NP	culture medium or culture medium only	794
@NP	controls	833
@NP	12 weeks after injury	847
@NP	12 weeks	847
@NP	injury	862
@NP	all grafted animals	870
@NP	cavitation	911
@NP	medium-injected rats	935
@NP	33 %	956
@NP	spinal tissue within a 5-mm-long segment of cord centered at the injury site	963
@NP	spinal tissue	963
@NP	a 5-mm-long segment of cord centered at the injury site	984
@NP	a 5-mm-long segment	984
@NP	cord centered at the injury site	1007
@NP	cord	1007
@NP	the injury site	1024
@NP	significantly more tissue	1052
@NP	SC -LRB- 51 % -RRB- , OEG -LRB- 43 % -RRB- , and SC/OEG -LRB- 44 % -RRB-	1092
@NP	SC -LRB- 51 % -RRB-	1092
@NP	SC	1092
@NP	51 %	1096
@NP	OEG -LRB- 43 % -RRB-	1102
@NP	OEG	1102
@NP	43 %	1107
@NP	SC/OEG -LRB- 44 % -RRB-	1117
@NP	SC/OEG	1117
@NP	44 %	1125
@NP	animals	1138
@NP	All three types of glial grafts	1147
@NP	All three types	1147
@NP	glial grafts	1166
@NP	axons	1196
@NP	spinal origin	1216
@NP	SC grafts	1231
@NP	more myelinated axons	1251
@NP	SC/OEG and OEG grafts	1278
@NP	Both types of SC-containing grafts	1301
@NP	Both types	1301
@NP	SC-containing grafts	1315
@NP	more intense staining	1346
@NP	glial fibrillary acidic protein and chondroitin sulfate proteoglycan	1372
@NP	OEG-only grafts	1455
@NP	Retrograde tracing	1472
@NP	Retrograde	1472
@NP	the number	1509
@NP	propriospinal and brainstem axons reaching 5 -- 6 mm beyond the grafted area	1523
@NP	propriospinal and brainstem axons	1523
@NP	5	1566
@NP	6 mm beyond the grafted area	1568
@NP	6 mm	1568
@NP	the grafted area	1580
@NP	SC and SC/OEG grafts	1627
@NP	OEG-only grafts	1661
@NP	controls	1691
@NP	Corticospinal fibers	1701
@NP	the lesion epicenter	1743
@NP	all grafted animals than in controls	1767
@NP	all	1767
@NP	animals	1779
@NP	controls	1795
@NP	SC-only grafts	1810
@NP	a modest but statistically significant improvement	1826
@NP	hindlimb locomotor performance	1880
@NP	8	1927
@NP	11 weeks	1929
@NP	injury	1944
@NP	addition to this functional improvement	1961
@NP	addition	1961
@NP	this functional improvement	1973
@NP	our results	2002
@NP	an SC graft	2024
@NP	axonal sparing/regeneration	2067
@NP	an SC/OEG or OEG graft in the moderately contused adult rat thoracic spinal cord	2100
@NP	an SC/OEG or OEG graft	2100
@NP	the moderately contused adult rat thoracic spinal cord	2126
@NP	adult rat	2150
@NP	Injury to the adult mammalian spinal cord	2183
@NP	Injury	2183
@NP	the adult mammalian spinal cord	2193
@NP	progressive tissue damage	2236
@NP	permanent functional deficits	2276
@NP	review	2311
@NP	Amar and Levy , 1999	2323
@NP	Amar and Levy	2323
@NP	1999	2338
@NP	Acute treatment	2345
@NP	antiinflammatory agents such as methylprednisolone -LRB- for review ,	2366
@NP	antiinflammatory agents	2366
@NP	methylprednisolone -LRB- for review ,	2398
@NP	methylprednisolone	2398
@NP	review	2422
@NP	Oudega et al. , 1999 ; Takami et al. , 2002 -RRB-	2434
@NP	Oudega	2434
@NP	et al.	2441
@NP	1999 ; Takami et al. , 2002	2449
@NP	1999	2449
@NP	Takami et al. , 2002	2455
@NP	Takami	2455
@NP	et al. , 2002	2462
@NP	et al.	2462
@NP	2002	2470
@NP	interleukin-10 -LRB- Bethea et al. , 1999 ; Takami et al. , 2002 -RRB-	2479
@NP	interleukin-10	2479
@NP	Bethea	2495
@NP	et al. , 1999 ; Takami et al. , 2002	2502
@NP	et al.	2502
@NP	1999 ; Takami et al.	2510
@NP	1999	2510
@NP	Takami et al.	2516
@NP	Takami	2516
@NP	et al.	2523
@NP	2002	2531
@NP	limits injury-induced tissue damage	2537
@NP	limits	2537
@NP	injury-induced tissue damage	2544
@NP	application of neuroprotective treatments	2591
@NP	application	2591
@NP	neuroprotective treatments	2606
@NP	severe functional deficits	2634
@NP	fact	2688
@NP	spinal cord injury -LRB- SCI -RRB-	2706
@NP	spinal cord injury	2706
@NP	SCI	2726
@NP	very poor clinical prospects	2735
@NP	Experimental strategies	2765
@NP	axonal sparing / regeneration	2808
@NP	axonal sparing	2808
@NP	axonal	2808
@NP	regeneration	2824
@NP	functional deficits	2851
@NP	there	2884
@NP	a window of opportunity for repair	2897
@NP	a window	2897
@NP	opportunity for repair	2909
@NP	opportunity	2909
@NP	repair	2925
@NP	SCI	2938
@NP	review	2947
@NP	Bunge , 2001 ; Jones et al. , 2001	2959
@NP	Bunge , 2001	2959
@NP	Bunge	2959
@NP	2001	2966
@NP	Jones et al. , 2001	2972
@NP	Jones	2972
@NP	et al. , 2001	2978
@NP	et al.	2978
@NP	2001	2986
@NP	Several cellular grafting strategies	2993
@NP	some behavioral improvements	3040
@NP	paralysis	3095
@NP	Iwashita	3106
@NP	et al. , 1994	3115
@NP	et al.	3115
@NP	1994	3123
@NP	Cheng et al. , 1996	3129
@NP	Cheng	3129
@NP	et al. , 1996	3135
@NP	et al.	3135
@NP	1996	3143
@NP	Grill et al. , 1997	3149
@NP	Grill	3149
@NP	et al. , 1997	3155
@NP	et al.	3155
@NP	1997	3163
@NP	Li et al. , 1997	3169
@NP	Li	3169
@NP	et al. , 1997	3172
@NP	et al.	3172
@NP	1997	3180
@NP	Liu et al. , 1999	3186
@NP	Liu	3186
@NP	et al. , 1999	3190
@NP	et al.	3190
@NP	1999	3198
@NP	McDonald et al. , 1999	3204
@NP	McDonald	3204
@NP	et al. , 1999	3213
@NP	et al.	3213
@NP	1999	3221
@NP	Ramo ' n-Cueto et al. , 2000	3227
@NP	Ramo ' n-Cueto et al.	3227
@NP	Ramo ' n-Cueto	3227
@NP	Ramo '	3227
@NP	et al.	3240
@NP	2000	3248
@NP	Coumans et al. , 2001	3254
@NP	Coumans	3254
@NP	et al. , 2001	3262
@NP	et al.	3262
@NP	2001	3270
@NP	An amply researched and reputable cell type for spinal cord repair	3277
@NP	An amply researched and reputable cell type	3277
@NP	spinal cord repair	3325
@NP	the Schwann cell -LRB- SC -RRB-	3347
@NP	the Schwann cell	3347
@NP	SC	3365
@NP	the myelin-forming glial cell of the peripheral nervous system	3370
@NP	the myelin-forming glial cell	3370
@NP	the peripheral nervous system	3403
@NP	review	3438
@NP	Bunge , 1994 ; Bunge and Kleitman , 1999	3450
@NP	Bunge , 1994	3450
@NP	Bunge	3450
@NP	1994	3457
@NP	Bunge and Kleitman , 1999	3463
@NP	Bunge and Kleitman	3463
@NP	1999	3483
@NP	An SC graft	3490
@NP	a transected adult rat	3511
@NP	thoracic spinal cord	3534
@NP	regeneration and myelination	3564
@NP	propriospinal axons -LRB- Xu et al. , 1995a , 1997 , 1999 -RRB-	3596
@NP	propriospinal axons	3596
@NP	Xu	3617
@NP	et al. , 1995a , 1997 , 1999	3620
@NP	et al.	3620
@NP	1995a	3628
@NP	1997	3635
@NP	1999	3641
@NP	The combination	3648
@NP	an SC graft	3667
@NP	methylprednisolone -LRB- Chen et al. , 1996 -RRB-	3684
@NP	methylprednisolone	3684
@NP	Chen	3704
@NP	et al. , 1996	3709
@NP	et al.	3709
@NP	1996	3717
@NP	neurotrophic factors	3731
@NP	Xu	3753
@NP	et al. , 1995b ; Menei et al. , 1998	3756
@NP	et al.	3756
@NP	1995b ; Menei et al.	3764
@NP	1995b	3764
@NP	Menei et al.	3771
@NP	Menei	3771
@NP	et al.	3777
@NP	1998	3785
@NP	axonal regeneration from brainstem neurons	3800
@NP	axonal regeneration	3800
@NP	brainstem neurons	3825
@NP	Another glial type that has shown promise in SCI repair	3852
@NP	Another glial type	3852
@NP	promise in SCI repair	3886
@NP	promise	3886
@NP	SCI repair	3897
@NP	olfactory ensheathing glia -LRB- OEG -RRB-	3911
@NP	olfactory ensheathing glia	3911
@NP	OEG	3939
@NP	review	3949
@NP	Franklin	3961
@NP	Barnett , 2000	3974
@NP	Barnett	3974
@NP	2000	3983
@NP	Kleitman and Bunge , 2000	3989
@NP	Kleitman and Bunge	3989
@NP	2000	4009
@NP	Ramo ' n-Cueto , 2000	4015
@NP	Ramo ' n-Cueto	4015
@NP	Ramo '	4015
@NP	2000	4029
@NP	Plant et al. , 2001	4035
@NP	Plant	4035
@NP	et al. , 2001	4041
@NP	et al.	4041
@NP	2001	4049
@NP	Raisman , 2001	4055
@NP	Raisman	4055
@NP	2001	4064
@NP	OEG grafts	4071
@NP	axonal growth and functional improvements	4090
@NP	different SCI models	4135
@NP	Li et al. , 1997 , 1998 ; Ramo ' n-Cueto et al. , 1998 , 2000	4157
@NP	Li et al.	4157
@NP	Li	4157
@NP	et al.	4160
@NP	1997 , 1998 ; Ramo ' n-Cueto et al.	4168
@NP	1997 , 1998	4168
@NP	1997	4168
@NP	1998	4174
@NP	Ramo ' n-Cueto et al.	4180
@NP	Ramo ' n-Cueto	4180
@NP	Ramo '	4180
@NP	et al.	4193
@NP	1998 , 2000	4201
@NP	1998	4201
@NP	2000	4207
@NP	an SC graft	4234
@NP	OEG placed into the transected cord stumps	4251
@NP	OEG	4251
@NP	the transected cord stumps	4267
@NP	the	4267
@NP	cord stumps	4282
@NP	regeneration	4303
@NP	axons	4344
@NP	the caudal and rostral cord , respectively	4355
@NP	the caudal and rostral cord	4355
@NP	Ramo ' n-Cueto et al. , 1998	4398
@NP	Ramo ' n-Cueto et al.	4398
@NP	Ramo ' n-Cueto	4398
@NP	Ramo '	4398
@NP	1998	4419
@NP	The repair abilities of SCs and OEG in the adult cord	4426
@NP	The repair abilities	4426
@NP	SCs and OEG	4450
@NP	the adult cord	4465
@NP	complete or partial transection models	4501
@NP	review	4545
@NP	Kleitman and Bunge , 2000 ; Ramo ' n-Cueto , 2000 ; Bunge , 2001 ; Plant et al.	4557
@NP	Kleitman and Bunge , 2000	4557
@NP	Kleitman and Bunge	4557
@NP	2000	4577
@NP	Ramo ' n-Cueto , 2000	4583
@NP	Ramo ' n-Cueto	4583
@NP	Ramo '	4583
@NP	2000	4597
@NP	Bunge , 2001	4603
@NP	Bunge	4603
@NP	2001	4610
@NP	Plant et al.	4616
@NP	Plant	4616
@NP	et al.	4622
@NP	2001	4630
@NP	demyelination models -LRB- for review , see Blakemore et al. , 2000 -RRB-	4643
@NP	demyelination models	4643
@NP	review , see Blakemore et al. , 2000	4669
@NP	review	4669
@NP	Blakemore	4681
@NP	et al. , 2000	4691
@NP	et al.	4691
@NP	2000	4699
@NP	also Imaizumi et al. , 1998 , 2000	4710
@NP	Imaizumi et al.	4715
@NP	Imaizumi	4715
@NP	et al.	4724
@NP	1998	4732
@NP	2000	4738
@NP	a common type of damage to the human spinal cord	4754
@NP	a common type	4754
@NP	damage to the human spinal cord	4771
@NP	damage	4771
@NP	the human spinal cord	4781
@NP	a contusive injury -LRB- Bunge et al. , 1997 ; Kakulas , 1999 -RRB-	4806
@NP	a contusive injury	4806
@NP	Bunge	4826
@NP	et al. , 1997 ; Kakulas , 1999	4832
@NP	et al.	4832
@NP	1997 ; Kakulas	4840
@NP	1997	4840
@NP	Kakulas	4846
@NP	1999	4855
@NP	studies	4862
@NP	the repair capacity of SCs -LRB- Martin et al. , 1991 , 1996 -RRB-	4873
@NP	the repair capacity	4873
@NP	SCs -LRB- Martin et al. , 1991 , 1996 -RRB-	4896
@NP	SCs	4896
@NP	Martin	4901
@NP	et al. , 1991 , 1996	4908
@NP	et al.	4908
@NP	1991	4916
@NP	1996	4922
@NP	OEG in clinically relevant contusion models	4932
@NP	OEG	4932
@NP	clinically relevant contusion models	4939
@NP	the present study	4991
@NP	the effects	5010
@NP	purified adult rat SCs	5025
@NP	OEG , or both ,	5051
@NP	OEG	5051
@NP	both	5059
@NP	spinal tissue sparing , axonal sparing/regeneration , and behavioral improvement	5068
@NP	spinal tissue sparing	5068
@NP	axonal sparing/regeneration	5091
@NP	behavioral improvement	5124
@NP	moderately contused adult Fischer rat thoracic spinal cord	5164
@NP	adult Fischer rat	5184
@NP	We	5224
@NP	the term `` sparing/regeneration '' in this paper	5232
@NP	the term `` sparing/regeneration ''	5232
@NP	this paper	5267
@NP	axons	5309
@NP	our knowledge	5346
@NP	this study	5361
@NP	the reparative capacity of SCs and OEG	5396
@NP	the reparative capacity	5396
@NP	SCs and OEG	5423
@NP	a clinically relevant contusive	5438
@NP	MATERIALS AND METHODS Schwann cell purification .	5482
@NP	MATERIALS AND METHODS	5482
@NP	MATERIALS	5482
@NP	METHODS	5496
@NP	Schwann cell purification	5504
@NP	Schwann	5504
@NP	cell purification	5512
@NP	Highly purified SC cultures	5531
@NP	sciatic nerve	5578
@NP	adult female Fischer rats	5595
@NP	Charles River Laboratories , Wilmington , MA	5622
@NP	Charles River Laboratories	5622
@NP	Wilmington , MA	5650
@NP	Morrissey	5691
@NP	et al. , 1991	5701
@NP	et al.	5701
@NP	1991	5709
@NP	the purity of the SCs used for grafting	5729
@NP	the purity	5729
@NP	the SCs used for grafting	5743
@NP	the SCs	5743
@NP	samples of the harvested SCs	5770
@NP	samples	5770
@NP	the harvested SCs	5781
@NP	culture dishes	5816
@NP	3 hr	5845
@NP	S100	5863
@NP	Citifluor -LRB- UKC Chemical Laboratory , Canterbury , England -RRB-	5896
@NP	Citifluor	5896
@NP	UKC Chemical Laboratory	5907
@NP	Canterbury	5932
@NP	England	5944
@NP	100 µM Hoechst nuclear dye -LRB- Sigma , St.	5964
@NP	100 µM Hoechst nuclear dye	5964
@NP	100 µM	5964
@NP	Hoechst nuclear	5971
@NP	Sigma	5992
@NP	St.	5999
@NP	Louis	6003
@NP	MO	6010
@NP	numbers of S100-positive cells	6025
@NP	numbers	6025
@NP	S100-positive cells	6036
@NP	Hoechst-labeled cells	6061
@NP	The purity of the SCs used for implantation	6084
@NP	The purity	6084
@NP	the SCs used for implantation	6098
@NP	the SCs	6098
@NP	implantation	6115
@NP	95 -- 98 %	6132
@NP	95	6132
@NP	98 %	6135
@NP	Olfactory ensheathing glia purification .	6140
@NP	Olfactory ensheathing glia	6140
@NP	purification	6167
@NP	Highly purified cultures of OEG	6181
@NP	Highly purified cultures	6181
@NP	OEG	6209
@NP	the nerve fiber layer	6232
@NP	the olfactory bulb	6257
@NP	adult female Fischer rats	6279
@NP	Ramo ' n-Cueto et al. , 1998	6330
@NP	Ramo ' n-Cueto et al.	6330
@NP	Ramo ' n-Cueto	6330
@NP	Ramo '	6330
@NP	1998	6351
@NP	Care	6358
@NP	the inclusion of non-nerve fiber layer bulb tissue	6385
@NP	the inclusion	6385
@NP	non-nerve fiber layer bulb tissue	6402
@NP	the pia	6441
@NP	The tissue	6462
@NP	Leibovitz-15 -LRB- L-15 -RRB-	6490
@NP	Leibovitz-15	6490
@NP	L-15	6504
@NP	Invitrogen , Gaithersburg	6518
@NP	MD	6544
@NP	HBSS -LRB- Invitrogen -RRB-	6567
@NP	HBSS	6567
@NP	Invitrogen	6573
@NP	small fragments	6597
@NP	HBSS with 0.25 % trypsin -LRB- Worthington Biochemical , Lake Wood , NJ -RRB-	6631
@NP	HBSS	6631
@NP	0.25 % trypsin -LRB- Worthington Biochemical , Lake Wood , NJ -RRB-	6641
@NP	0.25 % trypsin	6641
@NP	Worthington Biochemical , Lake Wood , NJ	6656
@NP	Worthington Biochemical , Lake Wood	6656
@NP	NJ	6692
@NP	50 µg/ml DNAase -LRB- Sigma -RRB- at 37 °C for 60 min	6700
@NP	50 µg/ml DNAase -LRB- Sigma -RRB-	6700
@NP	50 µg/ml DNAase	6700
@NP	Sigma	6717
@NP	37 °C for 60 min	6727
@NP	37 °C	6727
@NP	60 min	6736
@NP	Trypsinization	6744
@NP	DMEM/Ham 's	6781
@NP	F-12 -LRB- Invitrogen -RRB- -LRB- 1:1 mixture -RRB- supplemented with 10 % FBS	6792
@NP	F-12 -LRB- Invitrogen -RRB- -LRB- 1:1 mixture -RRB-	6792
@NP	F-12 -LRB- Invitrogen -RRB-	6792
@NP	F-12	6792
@NP	Invitrogen	6798
@NP	1:1 mixture	6811
@NP	10 % FBS	6842
@NP	50 µg/ml gentamicin -LRB- df-10S -RRB-	6854
@NP	50 µg/ml gentamicin	6854
@NP	df-10S	6875
@NP	The dissociated cells	6884
@NP	The	6884
@NP	cells	6900
@NP	df-10S plus 2 µM forskolin and 20 µg/ml pituitary extract	6940
@NP	df-10S plus 2 µM forskolin	6940
@NP	df-10S	6940
@NP	2 µM forskolin	6952
@NP	20 µg/ml pituitary extract	6971
@NP	20 µg/ml	6971
@NP	pituitary extract	6980
@NP	poly-L-lysine-coated culture dishes	7020
@NP	One week	7057
@NP	OEG	7073
@NP	other cell types	7097
@NP	immunopanning	7117
@NP	an antibody	7137
@NP	p75 , the low-affinity nerve growth factor receptor -LRB- gift of Dr.	7157
@NP	p75	7157
@NP	the low-affinity nerve growth factor receptor -LRB- gift of Dr.	7162
@NP	the low-affinity nerve growth factor receptor	7162
@NP	gift of Dr.	7209
@NP	gift	7209
@NP	Dr.	7217
@NP	Eric	7221
@NP	Shooter , Stanford University -RRB-	7226
@NP	a modification of the published protocol	7263
@NP	a modification	7263
@NP	the published protocol	7281
@NP	Ramo ' n-Cueto et al. , 1998	7305
@NP	Ramo ' n-Cueto et al.	7305
@NP	Ramo ' n-Cueto	7305
@NP	Ramo '	7305
@NP	1998	7326
@NP	Cells	7333
@NP	0.05 % trypsin and 0.02 % EDTA -LRB- Invitrogen -RRB-	7358
@NP	0.05 % trypsin	7358
@NP	0.05 %	7358
@NP	trypsin	7364
@NP	0.02 % EDTA -LRB- Invitrogen -RRB-	7376
@NP	0.02 %	7376
@NP	EDTA -LRB- Invitrogen -RRB-	7382
@NP	EDTA	7382
@NP	Invitrogen	7388
@NP	two times	7421
@NP	L-15	7447
@NP	antibody-treated dishes for 30 min at 4 °C	7472
@NP	antibody-treated dishes	7472
@NP	30 min at 4 °C	7500
@NP	30 min	7500
@NP	4 °C	7510
@NP	use	7522
@NP	these dishes	7527
@NP	overnight at 4 °C	7559
@NP	overnight	7559
@NP	4 °C	7572
@NP	anti-mouse IgG A	7581
@NP	M antibody -LRB- 1:100 in Tris buffer -RRB-	7598
@NP	M antibody	7598
@NP	1:100 in Tris buffer	7610
@NP	1:100	7610
@NP	Tris buffer	7619
@NP	0.05 M , pH 9.5 ; Jackson ImmunoResearch , West Grove , PA	7633
@NP	0.05 M	7633
@NP	pH 9.5 ; Jackson ImmunoResearch , West Grove	7641
@NP	pH 9.5	7641
@NP	Jackson ImmunoResearch , West Grove	7649
@NP	Jackson ImmunoResearch	7649
@NP	West Grove	7673
@NP	PA	7685
@NP	three times	7697
@NP	ice-cold L-15	7714
@NP	antibodies against p75 -LRB- 1:5 in L-15 medium with 5 % FBS -RRB-	7744
@NP	antibodies	7744
@NP	p75 -LRB- 1:5 in L-15 medium with 5 % FBS -RRB-	7763
@NP	p75	7763
@NP	1:5 in L-15 medium with 5 % FBS	7768
@NP	1:5	7768
@NP	L-15	7775
@NP	5 % FBS	7792
@NP	2 hr at 4 °C	7804
@NP	2 hr	7804
@NP	4 °C	7812
@NP	three times	7836
@NP	ice-cold L-15 medium	7853
@NP	The unattached cells	7875
@NP	the dishes	7914
@NP	gently five times	7937
@NP	ice-cold L-15 medium	7960
@NP	The attached cells	7982
@NP	df-10S plus 2 µM forskolin and 20 µg/ml pituitary extract	8010
@NP	df-10S plus 2 µM forskolin	8010
@NP	df-10S	8010
@NP	2 µM forskolin	8022
@NP	20 µg/ml pituitary extract	8041
@NP	20 µg/ml	8041
@NP	pituitary extract	8050
@NP	2 d	8072
@NP	37 °C in 6 % CO2	8079
@NP	37 °C	8079
@NP	6 % CO2	8087
@NP	the cells	8101
@NP	the dishes	8130
@NP	0.05 % trypsin and 0.02 % EDTA	8146
@NP	0.05 % trypsin	8146
@NP	0.02 % EDTA	8164
@NP	df-10S	8197
@NP	the cells	8214
@NP	DF-10S	8244
@NP	2 µM forskolin and 20 µg/ml	8256
@NP	2 µM forskolin	8256
@NP	20 µg/ml	8275
@NP	poly-lysine-coated culture dishes	8315
@NP	confluency	8369
@NP	DMEM/F -12	8404
@NP	transplantation	8419
@NP	Animals .	8436
@NP	Adult female Fischer rats	8445
@NP	n = 68 ; 160	8472
@NP	n =	8472
@NP	68 ; 160	8476
@NP	180 gm ; Charles River Laboratories	8484
@NP	180 gm	8484
@NP	Charles River Laboratories	8492
@NP	National Institutes of Health and United States Department	8545
@NP	Health and United	8568
@NP	Agriculture guidelines	8607
@NP	The Institutional Animal Care and Use Committee of the University of Miami	8631
@NP	The Institutional Animal Care and Use Committee	8631
@NP	the University of Miami	8682
@NP	the University	8682
@NP	Miami	8700
@NP	all animal procedures	8715
@NP	surgery	8745
@NP	the rats	8754
@NP	anesthetized with 1	8768
@NP	anesthetized	8768
@NP	1	8786
@NP	2 % halothane in a mixture of 70 % nitrous oxide and 30 % oxygen	8788
@NP	2 % halothane	8788
@NP	a mixture of 70 % nitrous oxide and 30 % oxygen	8804
@NP	a mixture	8804
@NP	70 % nitrous oxide and 30 % oxygen	8817
@NP	70 % nitrous oxide	8817
@NP	30 % oxygen	8839
@NP	An adequate level of anesthesia	8851
@NP	An adequate level	8851
@NP	anesthesia	8872
@NP	the corneal reflex and withdrawal	8912
@NP	the corneal reflex	8912
@NP	withdrawal	8935
@NP	painful stimuli for the hindlimbs	8949
@NP	painful stimuli	8949
@NP	the hindlimbs	8969
@NP	The back region	8984
@NP	betadine	9041
@NP	Bicillin -LRB- 0.02 ml/100 mg body weight , 300 U/ml , i.m. -RRB-	9051
@NP	Bicillin	9051
@NP	0.02 ml/100 mg	9061
@NP	body weight , 300 U/ml , i.m.	9076
@NP	body weight	9076
@NP	300 U/ml	9089
@NP	i.m.	9099
@NP	surgical procedures	9129
@NP	surgery	9172
@NP	the rats	9181
@NP	a heating pad	9203
@NP	the body temperature	9229
@NP	37 ± 0.5 °C	9253
@NP	37 ±	9253
@NP	0.5 °C	9258
@NP	Contusion injur y.	9265
@NP	Contusion	9265
@NP	injur y.	9275
@NP	Contusion injury	9284
@NP	the weight drop device	9316
@NP	New	9352
@NP	York University -LRB- Gruner , 1992 -RRB-	9356
@NP	York University	9356
@NP	Gruner	9373
@NP	1992	9381
@NP	the dura mater , the ninth thoracic -LRB- T9 -RRB-	9407
@NP	the dura mater	9407
@NP	the ninth thoracic	9423
@NP	T9	9443
@NP	spinal cord segment	9447
@NP	the dorsal part of the T8 vertebra	9491
@NP	the dorsal part	9491
@NP	the T8 vertebra	9510
@NP	The exposed cord	9527
@NP	a 10 gm weight that was dropped from a height of 12.5 mm	9576
@NP	a 10 gm weight	9576
@NP	a height of 12.5 mm	9613
@NP	a height	9613
@NP	12.5 mm	9625
@NP	The contusion impact velocity and compression	9634
@NP	The contusion impact velocity	9634
@NP	compression	9668
@NP	consistency between animals	9708
@NP	consistency	9708
@NP	animals	9728
@NP	injury	9743
@NP	the muscles	9751
@NP	layers	9779
@NP	the skin	9790
@NP	The rats were returned to their	9811
@NP	The rats	9811
@NP	their	9837
@NP	cages	9857
@NP	ad libitum access	9868
@NP	water and food	9889
@NP	Bicillin	9905
@NP	2 , 4 , and 6 d	9931
@NP	2	9931
@NP	4	9934
@NP	6 d	9941
@NP	the contusion injury	9951
@NP	The rats	9973
@NP	a total of 12 weeks	10002
@NP	a total	10002
@NP	12 weeks	10013
@NP	injury	10028
@NP	Glia transplantation .	10036
@NP	Glia	10036
@NP	transplantation	10041
@NP	One week	10058
@NP	injury	10073
@NP	the injury site	10081
@NP	a total of 2 x 10 ^ 6 SCs , OEG , or SC/OEG -LRB- 1 x 10 ^ 6 each -RRB-	10114
@NP	a total of 2	10114
@NP	a total	10114
@NP	2	10125
@NP	10 ^ 6 SCs , OEG	10129
@NP	10 ^ 6 SCs	10129
@NP	OEG	10139
@NP	SC/OEG -LRB- 1 x 10 ^ 6 each -RRB-	10147
@NP	SC/OEG	10147
@NP	1 x 10 ^ 6 each	10155
@NP	1 x	10155
@NP	10 ^ 6 each	10159
@NP	10 ^ 6	10159
@NP	each	10164
@NP	6 µl DMEM-F12 medium -LRB- G.	10173
@NP	6 µl DMEM-F12 medium	10173
@NP	G.	10195
@NP	W.	10198
@NP	Plant , E.	10201
@NP	Plant	10201
@NP	E.	10208
@NP	P.	10211
@NP	Cuervo , M.	10214
@NP	Cuervo	10214
@NP	M.	10222
@NP	L.	10225
@NP	Bates , M.	10228
@NP	Bates	10228
@NP	M.	10235
@NP	B.	10238
@NP	Bunge , and P.	10241
@NP	Bunge	10241
@NP	P.	10252
@NP	M.	10255
@NP	Wood	10258
@NP	unpublished observations	10264
@NP	the contused area using a 10 µl Hamilton syringe held in a micromanipulator	10308
@NP	the contused area	10308
@NP	a 10 µl Hamilton syringe	10332
@NP	a micromanipulator	10365
@NP	Control rats	10385
@NP	6 µl of DMEM-F12 medium	10417
@NP	6 µl	10417
@NP	DMEM-F12 medium	10425
@NP	injections	10448
@NP	the muscle layers and the skin	10460
@NP	the muscle layers	10460
@NP	the skin	10482
@NP	Sixtyeight rats	10515
@NP	medium -LRB- n = 21 -RRB-	10554
@NP	medium	10554
@NP	n	10562
@NP	21	10566
@NP	SCs -LRB- n = 15 -RRB-	10571
@NP	SCs	10571
@NP	n	10576
@NP	15	10580
@NP	OEG -LRB- n = 21 -RRB-	10585
@NP	OEG	10585
@NP	n	10590
@NP	21	10594
@NP	SC/OEG -LRB- n = 11 -RRB-	10602
@NP	SC/OEG	10602
@NP	n	10610
@NP	11	10614
@NP	The rats in each experimental group	10619
@NP	The rats	10619
@NP	each experimental group	10631
@NP	subgroups for retrograde and anterograde	10682
@NP	subgroups	10682
@NP	Anterograde	10732
@NP	anterograde axonal tracing , 9 weeks after contusion	10796
@NP	anterograde axonal tracing	10796
@NP	9 weeks after contusion	10824
@NP	9 weeks	10824
@NP	contusion	10838
@NP	the rats	10849
@NP	dextran amine	10893
@NP	BDA ; Molecular Probes	10908
@NP	BDA	10908
@NP	Molecular Probes	10913
@NP	Eugene , OR	10931
@NP	Eugene	10931
@NP	OR	10939
@NP	the hindlimb area of the motor cortex -LRB- 2 x 0.5 µl , bilateral -RRB-	10978
@NP	the hindlimb area	10978
@NP	the motor cortex -LRB- 2 x 0.5 µl , bilateral -RRB-	10999
@NP	the motor cortex	10999
@NP	2 x 0.5 µl , bilateral	11017
@NP	2 x	11017
@NP	0.5 µl	11021
@NP	bilateral	11029
@NP	dextran	11041
@NP	fluorescein -LRB- D/Fl ; Molecular Probes -RRB-	11060
@NP	fluorescein	11060
@NP	D/Fl ; Molecular Probes	11073
@NP	D/Fl	11073
@NP	Molecular Probes	11079
@NP	the reticular formation -LRB- 2 x 0.3 µl , bilateral -RRB-	11102
@NP	the reticular formation	11102
@NP	2 x 0.3 µl , bilateral	11127
@NP	2 x	11127
@NP	0.3 µl	11131
@NP	bilateral	11139
@NP	dextran	11155
@NP	rhodamine -LRB- D/Rho ; Molecular Probes -RRB-	11174
@NP	rhodamine	11174
@NP	D/Rho ; Molecular Probes	11185
@NP	D/Rho	11185
@NP	Molecular Probes	11192
@NP	the lateral vestibular nuclei	11215
@NP	2 x 0.2 µl , bilateral	11246
@NP	2 x	11246
@NP	0.2 µl	11250
@NP	bilateral	11258
@NP	retrograde neuronal tracing	11274
@NP	retrograde neuronal	11274
@NP	11 weeks	11303
@NP	the contusion injury	11318
@NP	the injury site	11340
@NP	a total of 0.6 µl of a 2 % aqueous fast blue solution -LRB- FB ; Sigma -RRB-	11373
@NP	a total	11373
@NP	0.6 µl of a 2 % aqueous fast blue solution -LRB- FB ; Sigma -RRB-	11384
@NP	0.6 µl	11384
@NP	a 2 % aqueous fast blue solution -LRB- FB ; Sigma -RRB-	11394
@NP	a 2 % aqueous fast blue solution	11394
@NP	2 %	11396
@NP	FB ; Sigma	11426
@NP	FB	11426
@NP	Sigma	11430
@NP	7 mm	11450
@NP	the distal laminectomy edge -LRB- in between vertebra T10 and T11 -RRB-	11465
@NP	the distal laminectomy edge	11465
@NP	vertebra T10 and T11	11505
@NP	a glass needle	11533
@NP	diameter , 200 µm	11549
@NP	diameter	11549
@NP	200 µm	11559
@NP	a 1 µl	11579
@NP	Hamilton syringe held in a micromanipulator -LRB- Takami et al. , 2002 -RRB-	11586
@NP	Hamilton syringe	11586
@NP	a micromanipulator -LRB- Takami et al. , 2002 -RRB-	11611
@NP	a micromanipulator	11611
@NP	Takami	11631
@NP	et al. , 2002	11638
@NP	et al.	11638
@NP	2002	11646
@NP	All injections	11653
@NP	a 3 min period	11687
@NP	the injection needle	11707
@NP	place for an additional 3 min	11740
@NP	place	11740
@NP	an additional 3 min	11750
@NP	leakage	11782
@NP	withdrawal	11793
@NP	the injection	11811
@NP	the muscles and skin	11826
@NP	the muscles	11826
@NP	skin	11842
@NP	layers	11862
@NP	Histological procedures	11870
@NP	12 weeks after injury	11898
@NP	12 weeks	11898
@NP	injury	11913
@NP	all rats	11921
@NP	2.57 mg ketamine	11949
@NP	0.51 mg xylazine	11967
@NP	0.09 mg acepromazine per 100 gm body weight	11989
@NP	0.09 mg acepromazine	11989
@NP	100 gm body weight	12014
@NP	phosphatebuffered , 4 % paraformaldehyde -LRB- 0.1 M , pH 7.4 -RRB-	12067
@NP	phosphatebuffered , 4 % paraformaldehyde	12067
@NP	0.1 M	12107
@NP	pH 7.4	12114
@NP	Takami	12123
@NP	et al. , 2002	12130
@NP	et al.	12130
@NP	2002	12138
@NP	The T7	12145
@NP	9 thoracic segments , which included the contusion injury ,	12152
@NP	9 thoracic segments	12152
@NP	the contusion injury	12188
@NP	gelatin -LRB- Oudega et al. , 1994 -RRB-	12241
@NP	gelatin	12241
@NP	Oudega	12250
@NP	et al. , 1994	12257
@NP	et al.	12257
@NP	1994	12265
@NP	a sliding freezing microtome	12278
@NP	the embedded cord segments	12308
@NP	40 - mthick horizontal sections	12349
@NP	40	12349
@NP	mthick horizontal sections	12353
@NP	mthick	12353
@NP	horizontal sections	12360
@NP	The T2 , C6 , and C2 spinal cord segments and the brainstem and cerebral cortex	12381
@NP	The T2 , C6 , and C2 spinal cord segments	12381
@NP	The T2 , C6 , and C2	12381
@NP	spinal cord segments	12400
@NP	the brainstem and cerebral cortex	12425
@NP	the brainstem	12425
@NP	cerebral cortex	12443
@NP	40-µm-thick transverse sections	12473
@NP	All sections	12506
@NP	PBS -LRB- 0.1 M , pH 7.4 -RRB-	12537
@NP	PBS	12537
@NP	0.1 M	12542
@NP	pH 7.4	12549
@NP	4 °C	12569
@NP	further processing	12579
@NP	electron microscopic analysis	12603
@NP	a 6-mm-long piece of the spinal cord with the epicenter in the middle	12634
@NP	a 6-mm-long piece	12634
@NP	the spinal cord with the epicenter in the middle	12655
@NP	the spinal cord	12655
@NP	the epicenter in the middle	12676
@NP	the epicenter	12676
@NP	the middle	12693
@NP	three 2-mm-long pieces	12735
@NP	These pieces	12759
@NP	analysis as described previously -LRB- Xu et al. , 1995a -RRB-	12790
@NP	analysis	12790
@NP	Xu	12824
@NP	et al. , 1995a	12827
@NP	et al.	12827
@NP	1995a	12835
@NP	Estimation of the number of myelinated axons and blood vessels in transplants .	12843
@NP	Estimation	12843
@NP	the number of myelinated axons and blood vessels	12857
@NP	the number	12857
@NP	myelinated axons and blood vessels	12871
@NP	transplants	12909
@NP	Estimated total numbers	12922
@NP	myelinated axons and blood vessels as well as the density	12949
@NP	myelinated axons and blood vessels	12949
@NP	the density	12995
@NP	myelinated axons	13010
@NP	the contusion lesion	13030
@NP	transplant area	13051
@NP	systematic random sampling -LRB- West , 1993 -RRB-	13086
@NP	systematic random sampling	13086
@NP	West , 1993	13114
@NP	West	13114
@NP	1993	13120
@NP	toluidine blue-stained , 1-µm-thick transverse plastic sections	13130
@NP	toluidine	13130
@NP	blue-stained , 1-µm-thick transverse plastic sections	13140
@NP	the	13194
@NP	transplanted area	13206
@NP	a fractionator grid , which ranged in size from 35 to 70 µm2	13260
@NP	a fractionator grid	13260
@NP	size	13297
@NP	35 to 70 µm2	13307
@NP	The objective lens used for all counts	13321
@NP	The objective lens	13321
@NP	all counts	13349
@NP	100x with oil immersion	13364
@NP	100x	13364
@NP	oil immersion	13374
@NP	the center of the fractionator grid	13392
@NP	the center	13392
@NP	the fractionator grid	13406
@NP	a 15 µm2 dissector probe	13429
@NP	All myelinated profiles within this dissector probe	13467
@NP	All myelinated profiles	13467
@NP	this dissector probe	13498
@NP	this way a fraction	13536
@NP	this way	13536
@NP	the lesion -- transplant area was analyzed	13559
@NP	the lesion	13559
@NP	transplant area	13570
@NP	optical fractionator method	13600
@NP	West	13630
@NP	1993	13636
@NP	proper use of this technique	13647
@NP	proper use	13647
@NP	this technique	13661
@NP	a minimum number of 150 -- 300 myelinated axons	13677
@NP	a minimum number	13677
@NP	150 -- 300 myelinated axons	13697
@NP	150	13697
@NP	300 myelinated axons	13701
@NP	lesion -- transplant area	13738
@NP	lesion	13738
@NP	transplant area	13745
@NP	our counts	13765
@NP	the number for myelinated axons	13777
@NP	the number	13777
@NP	myelinated axons	13792
@NP	between 159 and 484	13813
@NP	the exception	13839
@NP	67 in a medium-injected control animal , which contained a very large cavity	13856
@NP	67	13856
@NP	a medium-injected control animal , which contained a very large cavity	13862
@NP	a medium-injected control animal	13862
@NP	a very large cavity	13912
@NP	The estimation of the total number of myelinated axons and blood vessels	13933
@NP	The estimation	13933
@NP	the total number of myelinated axons and blood vessels	13951
@NP	the total number	13951
@NP	myelinated axons and blood vessels	13971
@NP	the Stereoinvestigator software	14020
@NP	MicroBrightfield	14053
@NP	Inc.	14071
@NP	Colchester , VT	14077
@NP	Quantitative assessment of anterograde and retrograde tracing .	14094
@NP	Quantitative assessment of anterograde and retrograde	14094
@NP	Quantitative assessment	14094
@NP	anterograde and retrograde	14121
@NP	quantitative analysis of the anterograde	14161
@NP	quantitative analysis	14161
@NP	the anterograde	14186
@NP	BDA-labeled corticospinal axons	14211
@NP	every fifth section of the T7 -- 9 cord segments	14260
@NP	every fifth section	14260
@NP	the T7 -- 9 cord segments	14283
@NP	the T7	14283
@NP	9 cord segments	14290
@NP	these sections	14314
@NP	the labeled axons	14330
@NP	a Nienhanced avidin -- biotin -- peroxidase staining	14370
@NP	Nienhanced avidin -- biotin --	14372
@NP	Nienhanced avidin	14372
@NP	biotin	14390
@NP	Oudega	14418
@NP	et al. , 1999	14425
@NP	et al.	14425
@NP	1999	14433
@NP	The number of BDA-labeled corticospinal axons	14440
@NP	The number	14440
@NP	BDA-labeled corticospinal axons	14454
@NP	all	14513
@NP	axons	14525
@NP	an imaginary line	14540
@NP	the rostral -- caudal axis of the spinal cord at 1 and 2	14582
@NP	the rostral	14582
@NP	caudal axis of the spinal cord at 1 and 2	14594
@NP	caudal axis	14594
@NP	the spinal cord at 1 and 2	14609
@NP	the spinal cord	14609
@NP	1 and 2	14628
@NP	the lesion epicenter	14657
@NP	The numbers of each section	14679
@NP	The numbers	14679
@NP	each section	14694
@NP	rat	14723
@NP	5	14750
@NP	the final number of labeled corticospinal axons	14762
@NP	the final number	14762
@NP	labeled corticospinal axons	14782
@NP	addition	14814
@NP	the T7 -- 9 segments	14829
@NP	the T7	14829
@NP	9 segments	14836
@NP	every fifth section	14848
@NP	gelatin-coated glass slides	14885
@NP	UKC Chemical Laboratory	14943
@NP	the nuclear	14979
@NP	Hoechst -LRB- 100 µM , Sigma -RRB-	14996
@NP	Hoechst	14996
@NP	100 µM	15005
@NP	Sigma	15013
@NP	the D/Fl-labeled reticulospinal axons	15041
@NP	the D/Rho-labeled vestibulospinal axons	15083
@NP	quantitative analysis of the retrograde	15128
@NP	quantitative analysis	15128
@NP	the retrograde	15153
@NP	every third horizontal section of the T7 -- 9 cord	15177
@NP	every third horizontal section	15177
@NP	the T7 -- 9 cord	15211
@NP	the T7	15211
@NP	9 cord	15218
@NP	gelatin-coated glass slides	15240
@NP	Citifluor -LRB- UKC Chemical Laboratory -RRB-	15290
@NP	Citifluor	15290
@NP	UKC Chemical Laboratory	15301
@NP	the T2 , C6 , and C2 cord segments	15331
@NP	the T2	15331
@NP	C6	15339
@NP	C2 cord segments	15347
@NP	every 5th transverse section	15365
@NP	the brainstem and cerebral cortex	15404
@NP	the brainstem	15404
@NP	cerebral cortex	15422
@NP	every 10th transverse section	15439
@NP	gelatin-coated slides	15486
@NP	Citifluor -LRB- UKC Chemical Laboratory -RRB-	15530
@NP	Citifluor	15530
@NP	UKC Chemical Laboratory	15541
@NP	each rat	15571
@NP	the number of FB-labeled neurons	15581
@NP	the number	15581
@NP	FB-labeled neurons	15595
@NP	each section	15632
@NP	These numbers	15646
@NP	rat	15676
@NP	3 -LRB- T9-T7 -RRB-	15698
@NP	3	15698
@NP	T9-T7	15701
@NP	5 -LRB- T2 , C6 , and C2 -RRB-	15709
@NP	5	15709
@NP	T2 , C6 , and C2	15712
@NP	T2	15712
@NP	C6	15716
@NP	C2	15724
@NP	10 -LRB- brainstem and cerebral cortex -RRB-	15732
@NP	10	15732
@NP	brainstem and cerebral cortex	15736
@NP	brainstem	15736
@NP	cerebral cortex	15750
@NP	the final number of labeled neurons	15777
@NP	the final number	15777
@NP	labeled neurons	15797
@NP	Assessment of spinal tissue sparing .	15814
@NP	Assessment	15814
@NP	spinal tissue sparing	15828
@NP	Every fifth horizontal section from the T7 -- 9 segment	15851
@NP	Every fifth horizontal section	15851
@NP	the T7 -- 9 segment	15887
@NP	the T7	15887
@NP	9 segment	15894
@NP	gelatin-coated glass slides	15921
@NP	cresyl violet	15963
@NP	Pro-Texx -LRB- Baxter Diagnostics , Deerfield , IL -RRB-	16010
@NP	Pro-Texx	16010
@NP	Baxter Diagnostics	16020
@NP	Deerfield	16040
@NP	IL	16051
@NP	the volume	16068
@NP	spared spinal tissue	16082
@NP	an image analysis computer system	16109
@NP	Universal Imaging , West Chester , PA	16144
@NP	Universal Imaging	16144
@NP	West Chester	16163
@NP	PA	16177
@NP	each section	16185
@NP	the total area	16199
@NP	a 5-mm-long cord segment with the lesion epicenter in the middle	16217
@NP	a 5-mm-long cord segment	16217
@NP	the lesion epicenter in the middle	16247
@NP	the lesion epicenter	16247
@NP	the middle	16271
@NP	the area of damaged spinal tissue	16286
@NP	the area	16286
@NP	damaged spinal tissue	16298
@NP	The border of the damaged area	16337
@NP	The border	16337
@NP	the damaged area	16351
@NP	an obvious discontinuity in density of small cells , i.e.	16383
@NP	an obvious discontinuity	16383
@NP	density of small cells	16411
@NP	density	16411
@NP	small cells	16422
@NP	transplanted cells	16441
@NP	inflammatory cells	16464
@NP	the absence of healthy-looking spinal neurons	16488
@NP	the absence	16488
@NP	healthy-looking spinal neurons	16503
@NP	this area	16549
@NP	small cysts	16569
@NP	The measurements of each section	16582
@NP	The measurements	16582
@NP	each section	16602
@NP	rat	16631
@NP	5	16653
@NP	every fifth section	16656
@NP	the total area	16698
@NP	the 5-mm-long cord segment	16716
@NP	damaged spinal tissue	16750
@NP	The volumes	16773
@NP	means of numerical integration	16809
@NP	means	16809
@NP	numerical integration	16818
@NP	The volume of spared spinal tissue within the 5-mm-long segment	16841
@NP	The volume	16841
@NP	spared spinal tissue within the 5-mm-long segment	16855
@NP	spared spinal tissue	16855
@NP	the 5-mm-long segment	16883
@NP	the volume of damaged tissue from the volume of the whole segment	16935
@NP	the volume	16935
@NP	damaged tissue from the volume of the whole segment	16949
@NP	damaged tissue	16949
@NP	the volume of the whole segment	16969
@NP	the volume	16969
@NP	the whole segment	16983
@NP	this value	17011
@NP	the percentage of the total volume of a 5-mm-long segment	17039
@NP	the percentage	17039
@NP	the total volume of a 5-mm-long segment	17057
@NP	the total volume	17057
@NP	a 5-mm-long segment	17077
@NP	the same cord level from normal , uninjured rats -LRB- n = 4 -RRB-	17102
@NP	the same cord level	17102
@NP	normal , uninjured rats -LRB- n = 4 -RRB-	17127
@NP	normal , uninjured rats	17127
@NP	n	17151
@NP	4	17155
@NP	Immunohistochemical procedures	17159
@NP	Every sixth horizontal section	17191
@NP	rabbit polyclonal antibodies , or both , following an earlier described	17281
@NP	rabbit polyclonal antibodies , or both ,	17281
@NP	rabbit polyclonal antibodies	17281
@NP	both	17314
@NP	an earlier described	17330
@NP	an earlier	17330
@NP	Takami	17361
@NP	et al. , 2002	17368
@NP	et al.	17368
@NP	2002	17376
@NP	The polyclonal antibodies used	17383
@NP	The polyclonal antibodies	17383
@NP	5-HT , 1:200	17435
@NP	5-HT	17435
@NP	1:200	17441
@NP	Incstar Corp. , Stillwater , MN -RRB- , anti-dopamine	17448
@NP	Incstar Corp. , Stillwater , MN -RRB- ,	17448
@NP	Incstar Corp.	17448
@NP	Stillwater	17463
@NP	MN	17475
@NP	betta-hydroxylase -LRB- DbettaH , 1:200 ; Incstar Corp. -RRB-	17495
@NP	betta-hydroxylase	17495
@NP	DbettaH , 1:200 ; Incstar Corp.	17514
@NP	DbettaH	17514
@NP	1:200 ; Incstar Corp.	17523
@NP	1:200	17523
@NP	Incstar Corp.	17530
@NP	anti-calcitonin gene-related peptide	17546
@NP	CGRP ; 1:100 ; Cappel , Aurora , OH	17584
@NP	CGRP	17584
@NP	1:100 ; Cappel , Aurora , OH	17590
@NP	1:100	17590
@NP	Cappel , Aurora , OH	17597
@NP	Cappel , Aurora	17597
@NP	OH	17613
@NP	anti-glial fibrillary acidic protein -LRB- GFAP , 1:400 ;	17622
@NP	anti-glial fibrillary acidic protein	17622
@NP	GFAP , 1:400	17660
@NP	GFAP	17660
@NP	1:400	17666
@NP	Dako , Carpinteria , CA	17673
@NP	The monoclonal antibodies used	17697
@NP	The monoclonal antibodies	17697
@NP	anti-low-affinity nerve growth factor receptor -LSB- p75 -LRB- 192IgG -RRB-	17733
@NP	anti-low-affinity nerve growth factor receptor	17733
@NP	p75 -LRB- 192IgG -RRB-	17781
@NP	p75	17781
@NP	192IgG	17786
@NP	1:1	17795
@NP	gift from Dr.	17800
@NP	gift	17800
@NP	Dr.	17810
@NP	E.	17814
@NP	Shooter	17817
@NP	Stanford University -RSB-	17826
@NP	antineurofilament	17848
@NP	RT-97 , 1:10 ; Developmental Hybridoma Bank	17867
@NP	RT-97	17867
@NP	1:10 ; Developmental Hybridoma Bank	17874
@NP	1:10	17874
@NP	Developmental Hybridoma Bank	17880
@NP	antichondroitin sulfate proteoglycan -LRB- CS-56 , 1:100 ; Sigma -RRB-	17911
@NP	antichondroitin sulfate proteoglycan	17911
@NP	CS-56 , 1:100 ; Sigma	17949
@NP	CS-56	17949
@NP	1:100 ; Sigma	17956
@NP	1:100	17956
@NP	Sigma	17963
@NP	anti-growth associated protein-43	17975
@NP	GAP-43 , 1:500 ; Boehringer Mannheim , Mannheim , Germany	18010
@NP	GAP-43	18010
@NP	1:500 ; Boehringer Mannheim	18018
@NP	1:500	18018
@NP	Boehringer Mannheim	18025
@NP	Mannheim , Germany	18046
@NP	The secondary antibodies used	18066
@NP	The secondary antibodies	18066
@NP	Alexa 488	18101
@NP	goat anti-rabbit -LRB- 1:200 ; Molecular Probes -RRB- and Alexa 594	18123
@NP	goat anti-rabbit	18123
@NP	1:200 ; Molecular Probes	18141
@NP	1:200	18141
@NP	Molecular Probes	18148
@NP	Alexa 594	18170
@NP	rabbit anti-mouse -LRB- 1:200 ; Molecular Probes -RRB-	18192
@NP	rabbit anti-mouse	18192
@NP	1:200 ; Molecular Probes	18211
@NP	1:200	18211
@NP	Molecular Probes	18218
@NP	The sections	18237
@NP	gelatin-coated glass slides	18268
@NP	Citifluor -LRB- UKC Chemical Laboratory -RRB-	18316
@NP	Citifluor	18316
@NP	UKC Chemical Laboratory	18327
@NP	100 µM Hoechst dye -LRB- Sigma -RRB-	18363
@NP	100 µM Hoechst dye	18363
@NP	100 µM	18363
@NP	Hoechst	18370
@NP	Sigma	18383
@NP	field locomotor test	18396
@NP	Hindlimb performance	18418
@NP	the open field locomotor test	18459
@NP	Basso	18502
@NP	et al. -LRB- 1995 , 1996 -RRB-	18508
@NP	et al.	18508
@NP	1995	18516
@NP	1996	18522
@NP	Two observers , unaware of the experimental procedures ,	18529
@NP	Two observers	18529
@NP	the experimental procedures	18555
@NP	the test	18594
@NP	a week	18608
@NP	9 weeks -LRB- for rats that received anterograde tracing -RRB-	18619
@NP	9 weeks	18619
@NP	rats that received anterograde tracing	18632
@NP	rats	18632
@NP	10 weeks -LRB- all other rats -RRB-	18675
@NP	all other rats	18685
@NP	Statistical analysis .	18702
@NP	One-way ANOVA followed by Fisher 's protected least-significant difference test	18724
@NP	One-way ANOVA	18724
@NP	Fisher 's protected least-significant difference test	18750
@NP	Fisher 's	18750
@NP	statistical differences between the average number of axons and neurons	18825
@NP	statistical differences	18825
@NP	the average number of axons and neurons	18857
@NP	the average number	18857
@NP	axons and neurons	18879
@NP	each group	18915
@NP	case of unequal variance -LRB- F test -RRB-	18939
@NP	case	18939
@NP	unequal variance -LRB- F test -RRB-	18947
@NP	unequal variance	18947
@NP	F test	18965
@NP	nonparametric analysis	18976
@NP	Kruskal -- Wallis test followed by Mann -- Whitney U test	19000
@NP	Kruskal	19000
@NP	Wallis test followed by Mann	19008
@NP	Wallis test	19008
@NP	Mann	19032
@NP	Whitney U test	19037
@NP	Whitney U	19037
@NP	test	19047
@NP	The latter test	19063
@NP	differences between the average Basso , Beattie , and Bresnahan -LRB- BBB -RRB-	19114
@NP	differences	19114
@NP	the average Basso , Beattie , and Bresnahan -LRB- BBB -RRB-	19134
@NP	the average Basso , Beattie	19134
@NP	Bresnahan	19166
@NP	BBB	19177
@NP	group	19192
@NP	A statistically significant difference	19230
@NP	p	19285
@NP	RESULTS Table 1 .	19296
@NP	RESULTS	19296
@NP	Table 1	19304
@NP	Estimated numbers	19313
@NP	myelinated axons and blood vessels in contusion lesion areas Figure 1	19334
@NP	myelinated axons and blood vessels	19334
@NP	contusion lesion areas Figure 1	19372
@NP	contusion lesion areas	19372
@NP	Figure 1	19396
@NP	Glial grafts	19406
@NP	contusion-induced spinal tissue damage	19425
@NP	Cresyl violet-stained horizontal sections of T9	19465
@NP	Cresyl violet-stained horizontal sections	19465
@NP	T9	19510
@NP	thoracic spinal cord	19513
@NP	3 months	19534
@NP	a moderate contusion injury and injection	19549
@NP	medium -LRB- A -RRB-	19594
@NP	medium	19594
@NP	A	19602
@NP	SCs -LRB- B -RRB-	19606
@NP	SCs	19606
@NP	B	19611
@NP	OEG -LRB- C -RRB-	19615
@NP	OEG	19615
@NP	C	19620
@NP	SCs/OEG -LRB- D -RRB-	19627
@NP	SCs/OEG	19627
@NP	D	19636
@NP	1 week	19639
@NP	injury	19652
@NP	Arrowheads	19660
@NP	the contusion impact site	19680
@NP	Black stars	19707
@NP	cystic cavities	19728
@NP	white stars	19749
@NP	blood between the dura mater and the spinal cord	19781
@NP	blood	19781
@NP	the dura mater and the spinal cord	19795
@NP	the dura mater	19795
@NP	the spinal cord	19814
@NP	GM , Gray matter	19831
@NP	GM	19831
@NP	Gray matter	19835
@NP	OEG , olfactory ensheathing glia transplant	19848
@NP	OEG	19848
@NP	olfactory ensheathing glia transplant	19853
@NP	SC , Schwann cell transplant	19892
@NP	SC	19892
@NP	Schwann cell transplant	19896
@NP	SC/EOG , transplant	19921
@NP	SC/EOG	19921
@NP	transplant	19929
@NP	Schwann cells and olfactory ensheating glia	19943
@NP	Schwann cells	19943
@NP	olfactory ensheating glia	19961
@NP	WM , white matter	19988
@NP	WM	19988
@NP	white matter	19992
@NP	Scale bar , 50 µm .	20006
@NP	Scale bar	20006
@NP	50 µm	20017
@NP	E	20024
@NP	Bar graph	20027
@NP	the volume	20045
@NP	spared spinal tissue	20059
@NP	the percentage -LRB- ± SEM -RRB-	20095
@NP	the percentage	20095
@NP	± SEM	20111
@NP	a 5-mm-long	20120
@NP	spinal segment -LRB- T9 cord segment -RRB- in an uninjured spinal cord	20141
@NP	spinal segment -LRB- T9 cord segment -RRB-	20141
@NP	spinal segment	20141
@NP	T9 cord segment	20157
@NP	an uninjured spinal cord	20177
@NP	Asterisks	20203
@NP	a significant difference -LRB- p < 0.05 -RRB-	20222
@NP	a significant difference	20222
@NP	p < 0.05	20248
@NP	p	20248
@NP	< 0.05	20250
@NP	<	20250
@NP	0.05	20252
@NP	the medium-injected control animals	20263
@NP	Figure 2 .	20301
@NP	Figure	20301
@NP	2	20308
@NP	Schwann cell transplants	20311
@NP	numerous myelinated axons	20344
@NP	the middle of the graft	20373
@NP	the middle	20373
@NP	the graft	20387
@NP	All panels	20398
@NP	toluidine	20414
@NP	blue-stained , 1-µm-thick plastic sections	20424
@NP	A , Control , medium-injected animal	20467
@NP	Control	20470
@NP	Stars	20503
@NP	cystic cavities	20518
@NP	B	20535
@NP	Higher magnification	20538
@NP	boxed area in A , demonstrating that SCs have migrated into the lesion area	20562
@NP	boxed area	20562
@NP	A	20576
@NP	SCs	20598
@NP	the lesion area	20621
@NP	the presence of peripheral-type myelin -LRB- arrows -RRB-	20654
@NP	the presence	20654
@NP	peripheral-type myelin -LRB- arrows -RRB-	20670
@NP	peripheral-type myelin	20670
@NP	arrows	20694
@NP	C , SC-transplanted animal .	20703
@NP	C	20703
@NP	SC-transplanted animal	20706
@NP	D , Higher magnification of boxed area in C.	20730
@NP	D , Higher magnification of boxed area	20730
@NP	D	20730
@NP	Higher magnification of boxed area	20733
@NP	Higher magnification	20733
@NP	boxed area	20757
@NP	C.	20771
@NP	Numerous myelinated axons -LRB- arrows -RRB-	20774
@NP	Numerous myelinated axons	20774
@NP	arrows	20801
@NP	the SC transplant	20828
@NP	E , OEG-transplanted animal .	20847
@NP	E	20847
@NP	OEG-transplanted animal	20850
@NP	F	20875
@NP	Higher magnification	20878
@NP	boxed area	20902
@NP	E	20916
@NP	a few myelinated axons -LRB- arrows -RRB- within the OEG transplant	20933
@NP	a few myelinated axons -LRB- arrows -RRB-	20933
@NP	a few myelinated axons	20933
@NP	arrows	20957
@NP	the OEG transplant	20972
@NP	DR , Dorsal root ; LC , lateral white column ; VC , ventral white column .	20992
@NP	DR , Dorsal root	20992
@NP	DR	20992
@NP	Dorsal root	20996
@NP	LC , lateral white column	21009
@NP	LC	21009
@NP	lateral white column	21013
@NP	VC , ventral white column	21035
@NP	VC	21035
@NP	ventral white column	21039
@NP	Scale bars : A , C , E , 300 µm ; B , D , F , 20 µm .	21061
@NP	Scale bars	21061
@NP	A , C , E , 300 µm	21073
@NP	A	21073
@NP	C	21076
@NP	E	21079
@NP	300 µm	21082
@NP	B , D , F , 20 µm	21090
@NP	B	21090
@NP	D	21093
@NP	F	21096
@NP	20 µm	21099
@NP	Figure 3 .	21107
@NP	Figure	21107
@NP	3	21114
@NP	SC-containing grafts	21117
@NP	more myelinated axons	21146
@NP	OEG-only grafts	21173
@NP	axons -LRB- at the right of the dashed line -RRB-	21207
@NP	axons	21207
@NP	the right of the dashed line	21217
@NP	the right	21217
@NP	the dashed line	21230
@NP	the cord near the cavity in a control animal	21260
@NP	the cord	21260
@NP	the cavity in a control animal	21274
@NP	the cavity	21274
@NP	a control animal	21288
@NP	host SCs	21319
@NP	the spinal cord	21342
@NP	the lesion site	21374
@NP	B	21391
@NP	SCs	21412
@NP	numerous SC-myelinated axons	21417
@NP	the lesion area	21463
@NP	12 weeks	21482
@NP	addition	21495
@NP	many axons of small diameter -LRB- arrows -RRB-	21505
@NP	many axons of small diameter	21505
@NP	many axons	21505
@NP	small diameter	21519
@NP	arrows	21535
@NP	nonmyelinating SCs	21572
@NP	C	21592
@NP	A few cells	21595
@NP	OEG	21621
@NP	SC/OEG grafting in areas near the lesion	21642
@NP	SC/OEG grafting	21642
@NP	areas near the lesion	21661
@NP	areas	21661
@NP	the lesion	21672
@NP	central myelin	21689
@NP	These	21717
@NP	OEG	21753
@NP	numerous naked axons	21774
@NP	-LRB- arrows -RRB-	21819
@NP	processes extended from the cells	21860
@NP	processes	21860
@NP	the cells	21884
@NP	The cells	21895
@NP	patches of basal lamina -LRB- asterisks -RRB-	21915
@NP	patches	21915
@NP	basal lamina -LRB- asterisks -RRB-	21926
@NP	basal lamina	21926
@NP	asterisks	21940
@NP	these cells	21967
@NP	oligodendrocytes	21988
@NP	All panels	22006
@NP	electron micrographs	22022
@NP	Scale bars : A , B , 4 µm ; C , 1 µm .	22044
@NP	Scale bars	22044
@NP	A	22056
@NP	B	22059
@NP	4 µm	22062
@NP	C , 1 µm	22068
@NP	C	22068
@NP	1 µm	22071
@NP	Figure 4 .	22078
@NP	Figure	22078
@NP	4	22085
@NP	glia	22101
@NP	CSPG	22123
@NP	sparing/regeneration of axons	22141
@NP	sparing/regeneration	22141
@NP	axons	22165
@NP	All panels	22172
@NP	photographs	22188
@NP	horizontal sections of the T9 cord segment 3 months	22211
@NP	horizontal sections	22211
@NP	the T9 cord segment	22234
@NP	3 months	22254
@NP	injury	22269
@NP	The presence of p75-positive cells	22277
@NP	The presence	22277
@NP	p75-positive cells	22293
@NP	medium - -LRB- A -RRB- , SC - -LRB- B -RRB-	22324
@NP	medium - -LRB- A -RRB- , SC -	22324
@NP	medium	22324
@NP	-LRB- A -RRB- , SC	22332
@NP	-LRB- A -RRB-	22332
@NP	SC	22337
@NP	B	22342
@NP	OEG - -LRB- C -RRB-	22350
@NP	OEG	22350
@NP	-LRB- C -RRB-	22355
@NP	animals	22368
@NP	the presence	22382
@NP	p75-positive cells	22398
@NP	the trabecula	22420
@NP	spinal tissue in the cavity -LRB- asterisks -RRB- in the medium-injected animal	22437
@NP	spinal tissue	22437
@NP	the cavity -LRB- asterisks -RRB- in the medium-injected animal	22454
@NP	the cavity -LRB- asterisks -RRB-	22454
@NP	the cavity	22454
@NP	asterisks	22466
@NP	the medium-injected animal	22480
@NP	A rim of GFAP-positive reactive astrocytes	22508
@NP	A rim	22508
@NP	GFAP-positive reactive astrocytes	22517
@NP	the spinal cord tissue	22570
@NP	the SC -LRB- D -RRB- , OEG -LRB- E -RRB- , or SC/OEG -LRB- F -RRB- graft	22605
@NP	the SC -LRB- D -RRB- , OEG -LRB- E -RRB- , or SC/OEG -LRB- F -RRB-	22605
@NP	the SC -LRB- D -RRB-	22605
@NP	the SC	22605
@NP	D	22613
@NP	OEG -LRB- E -RRB-	22617
@NP	OEG	22617
@NP	E	22622
@NP	SC/OEG -LRB- F -RRB-	22629
@NP	SC/OEG	22629
@NP	F	22637
@NP	Stars	22647
@NP	the transplants	22662
@NP	GFAP staining	22679
@NP	the SC -LRB- G -RRB- , OEG -LRB- H -RRB- , and SC/OEG -LRB- I -RRB-	22717
@NP	the SC -LRB- G -RRB-	22717
@NP	the SC	22717
@NP	G	22725
@NP	OEG -LRB- H -RRB-	22729
@NP	OEG	22729
@NP	H	22734
@NP	SC/OEG -LRB- I -RRB-	22742
@NP	SC/OEG	22742
@NP	I	22751
@NP	G , H , and I	22763
@NP	G	22763
@NP	H	22766
@NP	I	22773
@NP	higher magnifications of the boxed areas in D , E , and F , respectively	22779
@NP	higher magnifications	22779
@NP	the boxed areas in D , E , and F , respectively	22804
@NP	the	22804
@NP	areas in D , E , and F , respectively	22814
@NP	areas	22814
@NP	D , E , and F , respectively	22823
@NP	D , E , and F ,	22823
@NP	GFAP staining	22861
@NP	SC-containing grafts	22895
@NP	OEG-only grafts	22924
@NP	The presence of CSPG	22941
@NP	The presence	22941
@NP	CSPG	22957
@NP	an SC -LRB- J -RRB- , OEG -LRB- K -RRB- , or SC/OEG -LRB- L -RRB- graft	22981
@NP	an SC -LRB- J -RRB-	22981
@NP	an SC	22981
@NP	J	22989
@NP	OEG -LRB- K -RRB-	22993
@NP	OEG	22993
@NP	K	22998
@NP	SC/OEG -LRB- L -RRB- graft	23005
@NP	SC/OEG -LRB- L -RRB-	23005
@NP	SC/OEG	23005
@NP	L	23013
@NP	the SC graft	23046
@NP	CSPG	23066
@NP	the surrounding spinal tissue in animals receiving SC-containing grafts	23086
@NP	the surrounding spinal tissue	23086
@NP	animals receiving SC-containing grafts	23119
@NP	animals	23119
@NP	SC-containing grafts	23137
@NP	All transplants	23159
@NP	many neurofilament-positive axons	23185
@NP	M , an SC graft	23238
@NP	M	23238
@NP	an SC graft	23241
@NP	Some of the axons within the grafts	23254
@NP	Some	23254
@NP	the axons within the grafts	23262
@NP	the axons	23262
@NP	the grafts	23279
@NP	CGRP positive as shown in an SC transplant -LRB- N -RRB-	23295
@NP	CGRP	23295
@NP	an SC transplant -LRB- N -RRB-	23321
@NP	an SC transplant	23321
@NP	N	23339
@NP	Serotonergic axons	23343
@NP	gray matter	23382
@NP	rostral	23399
@NP	an SC graft -LRB- O -RRB-	23410
@NP	an SC graft	23410
@NP	O	23423
@NP	some	23432
@NP	the transplant -LRB- arrows -RRB-	23449
@NP	the transplant	23449
@NP	arrows	23465
@NP	GM , Gray matter	23474
@NP	GM	23474
@NP	Gray matter	23478
@NP	WM , white matter	23491
@NP	WM	23491
@NP	white matter	23495
@NP	OEG , olfactory ensheathing glia transplant	23509
@NP	OEG	23509
@NP	olfactory ensheathing glia transplant	23514
@NP	SC , Schwann cell transplant	23553
@NP	SC	23553
@NP	Schwann cell transplant	23557
@NP	SC/OEG , transplant containing Schwann cells and olfactory ensheathing glia	23582
@NP	SC/OEG	23582
@NP	transplant containing Schwann cells and olfactory ensheathing glia	23590
@NP	Schwann cells	23612
@NP	Scale bars	23658
@NP	A , 350 µm	23670
@NP	A	23670
@NP	350 µm	23673
@NP	B -- F , J	23681
@NP	B	23681
@NP	F , J	23683
@NP	F	23683
@NP	J	23686
@NP	M , 400 µm	23688
@NP	M	23688
@NP	400 µm	23691
@NP	G -- I , 100 µm	23699
@NP	G	23699
@NP	I , 100 µm	23701
@NP	I	23701
@NP	100 µm	23704
@NP	N , O , 200 µm	23712
@NP	N	23712
@NP	O	23715
@NP	200 µm	23718
@NP	Figure 5 .	23727
@NP	Figure	23727
@NP	5	23734
@NP	SC-containing grafts	23737
@NP	the most sparing/regeneration of propriospinal and supraspinal axons	23766
@NP	the most sparing/regeneration	23766
@NP	propriospinal and supraspinal axons	23799
@NP	FB-labeled neurons	23836
@NP	the T8	23871
@NP	7 cord segment in medium - -LRB- A -RRB- and SC - -LRB- B -RRB-	23878
@NP	7 cord segment	23878
@NP	medium - -LRB- A -RRB- and SC - -LRB- B -RRB-	23896
@NP	medium - -LRB- A -RRB- and SC -	23896
@NP	medium	23896
@NP	-LRB- A -RRB- and SC	23904
@NP	-LRB- A -RRB-	23904
@NP	SC	23912
@NP	B	23917
@NP	animals	23929
@NP	C	23938
@NP	Bar graph	23941
@NP	the total number of FB-labeled neurons -LRB- ± SEM -RRB-	23959
@NP	the total number	23959
@NP	FB-labeled neurons -LRB- ± SEM -RRB-	23979
@NP	FB-labeled neurons	23979
@NP	± SEM	23999
@NP	different levels of the spinal cord	24008
@NP	different levels	24008
@NP	the spinal cord	24028
@NP	FB-labeled neurons	24045
@NP	the reticular formation in medium - -LRB- D -RRB- and SC/OEG - -LRB- E -RRB-	24067
@NP	the reticular formation	24067
@NP	medium - -LRB- D -RRB- and SC/OEG - -LRB- E -RRB-	24094
@NP	medium - -LRB- D -RRB- and SC/OEG -	24094
@NP	medium	24094
@NP	-LRB- D -RRB- and SC/OEG	24102
@NP	-LRB- D -RRB-	24102
@NP	SC/OEG	24110
@NP	E	24119
@NP	animals	24131
@NP	F	24140
@NP	Bar graph	24143
@NP	the total number of FB-labeled neurons -LRB- ± SEM -RRB- in the brainstem	24161
@NP	the total number	24161
@NP	FB-labeled neurons -LRB- ± SEM -RRB- in the brainstem	24181
@NP	FB-labeled neurons -LRB- ± SEM -RRB-	24181
@NP	FB-labeled neurons	24181
@NP	± SEM	24201
@NP	the brainstem	24210
@NP	FB-labeled neuron	24225
@NP	the cerebral cortex in medium - -LRB- G -RRB- and OEG - -LRB- H -RRB-	24246
@NP	the cerebral cortex	24246
@NP	medium - -LRB- G -RRB- and OEG - -LRB- H -RRB-	24269
@NP	medium - -LRB- G -RRB- and OEG -	24269
@NP	medium	24269
@NP	-LRB- G -RRB- and OEG	24277
@NP	-LRB- G -RRB-	24277
@NP	OEG	24285
@NP	H	24291
@NP	animals	24303
@NP	I	24312
@NP	graph	24319
@NP	the total number of FB-labeled neurons -LRB- + SEM -RRB- in the cerebral cortex	24333
@NP	the total number	24333
@NP	FB-labeled neurons -LRB- + SEM -RRB- in the cerebral cortex	24353
@NP	FB-labeled neurons -LRB- + SEM -RRB-	24353
@NP	FB-labeled neurons	24353
@NP	+ SEM	24373
@NP	the cerebral cortex	24382
@NP	Single asterisks	24403
@NP	a significant difference of p < 0.05 from the medium-injected control animals	24429
@NP	a significant difference of p	24429
@NP	a significant difference	24429
@NP	p	24457
@NP	0.05	24461
@NP	the medium-injected control	24471
@NP	double asterisks	24508
@NP	a significant difference of p < 0.01 from the medium-injected control animals	24534
@NP	a significant difference of p	24534
@NP	a significant difference	24534
@NP	p	24562
@NP	0.01	24566
@NP	the medium-injected control	24576
@NP	CC , Central canal .	24613
@NP	CC	24613
@NP	Central canal	24617
@NP	Scale bar : A , B , 100 µm ; D -- H , 50 µm .	24632
@NP	Scale bar : A , B , 100 µm	24632
@NP	Scale bar : A , B ,	24632
@NP	Scale bar	24632
@NP	B	24646
@NP	100 µm	24649
@NP	D -- H , 50 µm	24657
@NP	D	24657
@NP	H , 50 µm	24659
@NP	H	24659
@NP	50 µm	24662
@NP	Figure 6 .	24670
@NP	Figure	24670
@NP	6	24677
@NP	Glial grafts	24680
@NP	corticospinal axon sparing/regeneration	24701
@NP	All panels except B show photographs	24742
@NP	All panels	24742
@NP	B show photographs	24760
@NP	horizontal 40 - m-thick sections	24790
@NP	horizontal 40	24790
@NP	m-thick sections	24805
@NP	A , BDA-labeled corticospinal axons in an OEG transplant -LRB- outlined -RRB- .	24823
@NP	A , BDA-labeled corticospinal axons in an OEG	24823
@NP	, BDA-labeled corticospinal axons in an	24824
@NP	, BDA-labeled corticospinal axons	24824
@NP	BDA-labeled	24826
@NP	an	24861
@NP	transplant -LRB- outlined -RRB-	24868
@NP	transplant	24868
@NP	B	24891
@NP	Bar graph	24894
@NP	the number of BDA-labeled axons -LRB- SEM -RRB-	24912
@NP	the number	24912
@NP	BDA-labeled axons -LRB- SEM -RRB-	24926
@NP	BDA-labeled axons	24926
@NP	SEM	24946
@NP	different levels within the glial transplants	24954
@NP	different levels	24954
@NP	the glial transplants	24978
@NP	Single asterisks	25001
@NP	a significant difference of p < 0.05 from the medium-injected control animals	25027
@NP	a significant difference of p	25027
@NP	a significant difference	25027
@NP	p	25055
@NP	0.05	25059
@NP	the medium-injected control	25069
@NP	double asterisks	25106
@NP	a significant difference of p	25132
@NP	a significant difference	25132
@NP	p	25160
@NP	0.01	25164
@NP	controls	25174
@NP	C	25184
@NP	Dextran-rhodamine-labeled vestibulospinal axons	25187
@NP	the lateral white matter columns -LRB- LC -RRB-	25238
@NP	the lateral white matter columns	25238
@NP	LC	25272
@NP	the level of the lesion epicenter	25279
@NP	the level	25279
@NP	the lesion epicenter	25292
@NP	D	25314
@NP	Dextran-fluorescein-labeled reticulospinal axons	25317
@NP	the lateral white matter columns -LRB- LC -RRB-	25369
@NP	the lateral white matter columns	25369
@NP	LC	25403
@NP	the level of the lesion epicenter	25410
@NP	the level	25410
@NP	the lesion epicenter	25423
@NP	Scale bars , 100 µm .	25445
@NP	Scale bars	25445
@NP	100 µm	25457
@NP	Figure 7 .	25466
@NP	Figure	25466
@NP	7	25473
@NP	Transplantation of SC or SC/OEG 1 week after moderate contusion	25476
@NP	Transplantation	25476
@NP	SC or SC/OEG 1 week after moderate contusion	25495
@NP	SC or SC/OEG	25495
@NP	1 week	25508
@NP	moderate contusion	25521
@NP	hindlimb performance	25549
@NP	Bar graph	25571
@NP	the average open-field BBB score at different times	25587
@NP	the average open-field BBB score	25587
@NP	different times	25623
@NP	injury	25645
@NP	Locomotor function of the hindlimbs	25653
@NP	Locomotor function	25653
@NP	the hindlimbs	25675
@NP	blindly once a week	25703
@NP	11 weeks	25727
@NP	Data	25737
@NP	means	25759
@NP	SEM	25767
@NP	Single asterisks	25772
@NP	a significant difference -LRB- p < 0.05 -RRB-	25798
@NP	a significant difference	25798
@NP	p < 0.05	25825
@NP	p	25825
@NP	< 0.05	25827
@NP	<	25827
@NP	0.05	25829
@NP	the medium-injected control animals	25840
@NP	the control group	25891
@NP	the SC-transplanted group	25910
@NP	a significantly higher BBB score	25940
@NP	8	25976
@NP	11 weeks	25978
@NP	The SC/OEG group	26003
@NP	a significantly higher score	26024
@NP	one time point , 8 weeks	26061
@NP	one time point	26061
@NP	8 weeks	26077
@NP	SC and OEG transplants	26103
@NP	tissue	26134
@NP	medium-injected animals	26152
@NP	12 weeks after a moderate contusion injury , large cysts	26177
@NP	12 weeks	26177
@NP	a moderate contusion injury , large cysts	26192
@NP	a moderate contusion injury	26192
@NP	large cysts	26221
@NP	the rostral -- caudal direction -LRB- Fig. 1A -RRB-	26259
@NP	the rostral	26259
@NP	caudal direction	26271
@NP	Fig. 1A	26289
@NP	These cysts	26299
@NP	the lesion epicenter	26326
@NP	transplanted animals	26351
@NP	the glial grafts	26373
@NP	host spinal tissue -LRB- Fig. 1B -- D -RRB-	26411
@NP	host spinal tissue	26411
@NP	Fig. 1B -- D	26431
@NP	Fig. 1B	26431
@NP	D	26439
@NP	some small cavities	26452
@NP	Fig. 1C , D	26491
@NP	Fig. 1C	26491
@NP	D	26499
@NP	The effect of SC and OEG grafts on tissue sparing	26503
@NP	The effect	26503
@NP	SC and OEG grafts on tissue sparing	26517
@NP	SC and OEG grafts	26517
@NP	tissue sparing	26538
@NP	the volume of damaged tissue -LRB- including cavities and transplant -RRB-	26581
@NP	the volume	26581
@NP	damaged tissue	26595
@NP	cavities and transplant	26621
@NP	cavities	26621
@NP	transplant	26634
@NP	a 5-mm-long cord segment	26653
@NP	the epicenter in the middle of the section	26684
@NP	the epicenter	26684
@NP	the middle of the section	26701
@NP	the middle	26701
@NP	the section	26715
@NP	the total volume of this segment	26733
@NP	the total volume	26733
@NP	this segment	26753
@NP	This value	26767
@NP	a percentage of the volume of the comparable -LRB- T9 -RRB- segment	26795
@NP	a percentage	26795
@NP	the volume of the comparable -LRB- T9 -RRB- segment	26811
@NP	the volume	26811
@NP	the comparable -LRB- T9 -RRB- segment	26825
@NP	T9	26841
@NP	uninjured rats	26856
@NP	The volume	26872
@NP	a 5-mm-long spinal cord segment of a normal , uninjured rat at the T9 level	26886
@NP	a 5-mm-long spinal cord segment	26886
@NP	a normal , uninjured rat at the T9 level	26921
@NP	a normal , uninjured rat	26921
@NP	the T9 level	26948
@NP	21.2 ± 0.9 mm3 -LRB- SEM ; n = 4 -RRB-	26965
@NP	21.2 ± 0.9 mm3	26965
@NP	21.2 ±	26965
@NP	0.9 mm3	26972
@NP	SEM ; n = 4	26981
@NP	SEM	26981
@NP	n = 4	26986
@NP	n	26986
@NP	4	26990
@NP	control medium-injected animals	26997
@NP	the volume of spared tissue	27030
@NP	the volume	27030
@NP	spared tissue	27044
@NP	6.9 ± 0.7 mm3 -LRB- n = 8 -RRB-	27062
@NP	6.9 ± 0.7 mm3	27062
@NP	6.9 ±	27062
@NP	0.7 mm3	27068
@NP	n	27077
@NP	8	27081
@NP	33 ±	27088
@NP	the volume of the comparable segment of an uninjured rat -LRB- Fig. 1E -RRB-	27099
@NP	the volume	27099
@NP	the comparable segment of an uninjured rat -LRB- Fig. 1E -RRB-	27113
@NP	the comparable segment	27113
@NP	an uninjured rat -LRB- Fig. 1E -RRB-	27139
@NP	an uninjured rat	27139
@NP	Fig. 1E	27157
@NP	an SC or OEG graft	27172
@NP	the volume of spared tissue	27192
@NP	the volume	27192
@NP	spared tissue	27206
@NP	10.8 ± 1.5 mm3 -LRB- n = 5 -RRB-	27224
@NP	10.8 ± 1.5 mm3	27224
@NP	10.8 ±	27224
@NP	1.5 mm3	27231
@NP	n	27240
@NP	5	27244
@NP	9.1 ± 0.8 mm3 -LRB- n = 9 -RRB- , or 51 ± 7 and 43 ± 4 % , respectively	27251
@NP	9.1 ± 0.8 mm3 -LRB- n = 9 -RRB-	27251
@NP	9.1 ± 0.8 mm3	27251
@NP	9.1 ±	27251
@NP	0.8 mm3	27257
@NP	n	27266
@NP	9	27270
@NP	51 ± 7 and 43 ± 4 %	27277
@NP	51 ±	27277
@NP	7 and 43 ± 4 %	27282
@NP	the volume	27314
@NP	the comparable segment in a normal , uninjured cord -LRB- Fig. 1E -RRB-	27328
@NP	the comparable segment	27328
@NP	a normal , uninjured cord -LRB- Fig. 1E -RRB-	27354
@NP	a normal , uninjured cord	27354
@NP	Fig. 1E	27380
@NP	These values	27390
@NP	the volume of spared tissue in medium-injected animals	27435
@NP	the volume	27435
@NP	spared tissue in medium-injected animals	27449
@NP	spared tissue	27449
@NP	medium-injected animals	27466
@NP	the combination of SCs and OEG	27500
@NP	the combination	27500
@NP	SCs and OEG	27519
@NP	a volume of 9.4	27543
@NP	a volume	27543
@NP	9.4	27555
@NP	± 1.1 mm3 -LRB- n = 5 -RRB- of spared tissue	27559
@NP	± 1.1 mm3 -LRB- n = 5 -RRB-	27559
@NP	± 1.1 mm3	27559
@NP	n	27570
@NP	5	27574
@NP	spared tissue	27580
@NP	44 ± 5 % of the comparable segment in an uninjured cord -LRB- Fig. 1E -RRB-	27598
@NP	44 ±	27598
@NP	the comparable segment in an uninjured cord -LRB- Fig. 1E -RRB-	27609
@NP	the comparable segment	27609
@NP	an uninjured cord -LRB- Fig. 1E -RRB-	27635
@NP	an uninjured cord	27635
@NP	Fig. 1E	27654
@NP	p < 0.05	27695
@NP	p	27695
@NP	< 0.05	27697
@NP	<	27697
@NP	0.05	27699
@NP	the mediuminjected control animals	27721
@NP	These results	27757
@NP	implantation	27788
@NP	SC or OEG grafts , or both , into a 1-week-old moderate contusion lesion	27804
@NP	SC or OEG grafts , or both ,	27804
@NP	SC or OEG grafts	27804
@NP	both	27825
@NP	a 1-week-old moderate contusion lesion	27836
@NP	spinal tissue sparing	27884
@NP	All grafts	27907
@NP	myelinated axons	27926
@NP	12 weeks after injury , i.e. , 11 weeks after implantation	27946
@NP	12 weeks after injury , i.e. ,	27946
@NP	12 weeks after injury	27946
@NP	12 weeks	27946
@NP	injury	27961
@NP	11 weeks	27975
@NP	implantation	27990
@NP	toluidine	28004
@NP	1 µm plastic cross-sections of the lesion epicenter	28028
@NP	1 µm plastic cross-sections	28028
@NP	the lesion epicenter	28059
@NP	the presence of myelinated axons	28105
@NP	the presence	28105
@NP	myelinated axons	28121
@NP	the transplants	28156
@NP	medium-injected control animals	28176
@NP	some tissue	28209
@NP	the large cavities -LRB- Fig. 2A -RRB-	28246
@NP	the large cavities	28246
@NP	Fig. 2A	28266
@NP	This tissue	28276
@NP	axons	28298
@NP	typical peripheral-type -LRB- SC -RRB- myelin -LRB- Fig. 2B -RRB-	28318
@NP	typical peripheral-type -LRB- SC -RRB- myelin	28318
@NP	SC	28343
@NP	Fig. 2B	28355
@NP	The criteria to recognize peripheral-type myelin in plastic cross sections	28365
@NP	peripheral-type myelin in plastic cross sections	28391
@NP	plastic cross	28417
@NP	the presence	28445
@NP	a signet ring configuration	28461
@NP	myelin ring with the proximate SC nucleus	28490
@NP	myelin ring	28490
@NP	the proximate SC nucleus	28507
@NP	the presence	28537
@NP	space	28553
@NP	the myelinated axons	28567
@NP	the formation of extracellular matrix -LRB- Bunge et al. , 1994 -RRB-	28608
@NP	the formation	28608
@NP	extracellular matrix -LRB- Bunge et al. , 1994 -RRB-	28625
@NP	extracellular matrix	28625
@NP	Bunge	28647
@NP	et al. , 1994	28653
@NP	et al.	28653
@NP	1994	28661
@NP	contrast	28671
@NP	central-type myelin profiles	28681
@NP	adjacent nuclei	28725
@NP	little or no space between them	28750
@NP	little or no space	28750
@NP	them	28777
@NP	controls as well as in grafted animals	28786
@NP	controls	28786
@NP	in grafted animals	28806
@NP	in	28806
@NP	animals	28817
@NP	a rim	28826
@NP	preserved spinal white matter	28835
@NP	axons with typical central-type -LRB- oligodendrocyte -RRB-	28880
@NP	axons	28880
@NP	typical central-type -LRB- oligodendrocyte -RRB-	28891
@NP	the dorsal aspect of this rim	28954
@NP	the dorsal aspect	28954
@NP	this rim	28975
@NP	both peripheral and central types of myelin	28985
@NP	peripheral and central types of myelin	28990
@NP	peripheral and central types	28990
@NP	myelin	29022
@NP	the presence	29052
@NP	SCs that had migrated from the dorsal roots into the damaged spinal cord	29068
@NP	SCs	29068
@NP	the dorsal roots	29095
@NP	the damaged spinal cord	29117
@NP	All types of grafts	29142
@NP	All types	29142
@NP	grafts	29155
@NP	axons surrounded by peripheraltype myelin -LRB- Fig. 2B , D , F -RRB-	29172
@NP	axons	29172
@NP	peripheraltype myelin -LRB- Fig. 2B , D , F -RRB-	29192
@NP	peripheraltype myelin	29192
@NP	Fig. 2B , D	29215
@NP	F	29225
@NP	the SC graft	29238
@NP	more axons than the other types of grafts -LRB- Fig. 2 ,	29269
@NP	more axons	29269
@NP	the other types of grafts -LRB- Fig. 2 ,	29285
@NP	the other types of grafts	29285
@NP	the other types	29285
@NP	grafts	29304
@NP	Fig. 2	29312
@NP	D , F ; Table 1	29328
@NP	D , F	29328
@NP	D	29328
@NP	F	29331
@NP	Table 1	29334
@NP	We	29344
@NP	the total number	29357
@NP	myelinated axons and blood vessels in the contusion lesion area	29377
@NP	myelinated axons and blood vessels	29377
@NP	the contusion lesion area	29415
@NP	image analysis	29444
@NP	the optical fractionator method -LRB- West , 1993 -RRB-	29465
@NP	the optical fractionator method	29465
@NP	West , 1993	29498
@NP	West	29498
@NP	1993	29504
@NP	Stereoinvestigator program	29511
@NP	SC-injected animals -LRB- Fig. 2C , D -RRB-	29543
@NP	SC-injected animals	29543
@NP	Fig. 2C , D	29564
@NP	Fig. 2C	29564
@NP	D	29572
@NP	the number of myelinated axons	29576
@NP	the number	29576
@NP	myelinated axons	29590
@NP	± 1783	29616
@NP	mean ± SEM ; n = 2	29624
@NP	mean ± SEM	29624
@NP	n = 2	29636
@NP	n	29636
@NP	2	29640
@NP	2125 ± 697 -LRB- n = 3 -RRB- in medium-injected animals	29657
@NP	2125 ± 697	29657
@NP	n	29669
@NP	3	29673
@NP	medium-injected animals	29679
@NP	Table 1	29704
@NP	OEG-injected animals -LRB- Fig. 2E , F -RRB-	29717
@NP	OEG-injected animals	29717
@NP	Fig. 2E , F	29739
@NP	Fig. 2E	29739
@NP	F	29747
@NP	the number of axons with peripheral-type myelin	29751
@NP	the number	29751
@NP	axons with peripheral-type myelin	29765
@NP	axons	29765
@NP	peripheral-type myelin	29776
@NP	2965 ± 1110 -LRB- n = 3 -RRB-	29803
@NP	2965	29803
@NP	± 1110 -LRB- n = 3 -RRB-	29808
@NP	± 1110	29808
@NP	n	29816
@NP	3	29820
@NP	SC/OEG grafts , 3884 ±	29831
@NP	SC/OEG grafts	29831
@NP	3884 ±	29846
@NP	711 -LRB- n = 3 -RRB-	29853
@NP	711	29853
@NP	n	29858
@NP	3	29862
@NP	The density of myelinated axons	29866
@NP	The density	29866
@NP	myelinated axons	29881
@NP	75.8 ± 31.9 myelinated axons per 0.1 mm2 in SC grafts	29902
@NP	75.8	29902
@NP	± 31.9 myelinated axons per 0.1 mm2 in SC grafts	29907
@NP	± 31.9 myelinated axons	29907
@NP	0.1 mm2 in SC grafts	29935
@NP	0.1 mm2	29935
@NP	SC grafts	29946
@NP	32.3 ± 7.01 in OEG grafts	29957
@NP	32.3 ± 7.01	29957
@NP	OEG grafts	29972
@NP	40.2 ± 21.5 in SC/OEG grafts	29984
@NP	40.2	29984
@NP	± 21.5 in SC/OEG grafts	29989
@NP	± 21.5	29989
@NP	SC/OEG grafts	29999
@NP	26.9 ± 12.2 in medium-injected animals	30018
@NP	26.9 ± 12.2	30018
@NP	medium-injected animals	30033
@NP	The number of blood vessels	30058
@NP	The number	30058
@NP	blood vessels	30072
@NP	all groups -LRB- Table 1 -RRB-	30101
@NP	all groups	30101
@NP	Table 1	30113
@NP	electron micrographs	30126
@NP	peripheral-type myelin	30148
@NP	the presence of an external collar of SC cytoplasm	30188
@NP	the presence	30188
@NP	an external collar of SC cytoplasm	30204
@NP	an external collar	30204
@NP	SC cytoplasm	30226
@NP	a basal lamina	30240
@NP	collagen fibers that run parallel to the myelin sheath	30260
@NP	collagen fibers	30260
@NP	parallel	30285
@NP	the myelin sheath	30297
@NP	Central-type myelin	30316
@NP	these features	30353
@NP	The electron micrograph in Figure 3A	30369
@NP	The electron micrograph	30369
@NP	Figure 3A	30396
@NP	central - and peripheral-type myelin in tissue next to a cavity	30418
@NP	central - and peripheral-type myelin	30418
@NP	tissue next to a cavity	30457
@NP	tissue	30457
@NP	a cavity	30472
@NP	this area from a control animal	30494
@NP	this area	30494
@NP	a control animal	30509
@NP	there	30526
@NP	membrane	30557
@NP	other areas	30578
@NP	it	30590
@NP	the interface between central tissue	30620
@NP	the interface	30620
@NP	central tissue	30642
@NP	SCs	30670
@NP	A wide range	30675
@NP	degree	30691
@NP	glial	30701
@NP	membrane -LRB- basal lamina and highly filamentous astrocytic processes -RRB-	30716
@NP	membrane	30716
@NP	basal lamina and highly filamentous astrocytic processes	30726
@NP	basal lamina	30726
@NP	highly filamentous astrocytic processes	30743
@NP	grafted animals	30805
@NP	Fasciculation and perineurium formation	30822
@NP	the SC area in Figure 3A	30882
@NP	the SC area	30882
@NP	Figure 3A	30897
@NP	all animals examined	30911
@NP	all animals	30911
@NP	perineurium	30933
@NP	12 weeks	30977
@NP	This	30987
@NP	comparison	31010
@NP	other lesion models	31026
@NP	the photochemical lesion	31054
@NP	fasciculation and perineurial development in SC areas	31086
@NP	fasciculation and perineurial development	31086
@NP	SC areas	31131
@NP	Bunge	31155
@NP	et al. , 1994	31161
@NP	et al.	31161
@NP	1994	31169
@NP	SC-related axons	31176
@NP	blood vessels	31221
@NP	Occasional macrophages	31236
@NP	all samples	31272
@NP	the lesion or transplant	31290
@NP	thin central myelin	31316
@NP	thin	31316
@NP	remyelination	31364
@NP	oligodendrocytes	31381
@NP	Figure 3B	31399
@NP	the electron microscopic level	31424
@NP	the presence of many axons with typical SC myelin in the middle of an SC graft	31455
@NP	the presence	31455
@NP	many axons with typical SC myelin in the middle of an SC graft	31471
@NP	many axons	31471
@NP	typical SC myelin in the middle of an SC graft	31487
@NP	typical SC	31487
@NP	the middle of an SC graft	31508
@NP	the middle	31508
@NP	an SC graft	31522
@NP	Both myelinated and unmyelinated axons	31535
@NP	the SCs	31592
@NP	basal lamina	31619
@NP	Axons	31633
@NP	diameter	31662
@NP	both SC - and SC/OEG-grafted animals	31675
@NP	both SC	31675
@NP	SC/OEG-grafted animals	31688
@NP	the myelin in the grafts	31712
@NP	the myelin	31712
@NP	the grafts	31726
@NP	the peripheral type	31744
@NP	most SC/OEG - and OEG-grafted animals	31768
@NP	most SC/OEG	31768
@NP	OEG-grafted animals	31785
@NP	it	31806
@NP	the OEG	31838
@NP	OEG grafts	31860
@NP	the myelin	31872
@NP	SCs	31901
@NP	it	31910
@NP	the myelin	31951
@NP	OEG or host SCs	31981
@NP	one area of an SC/OEG graft	32001
@NP	one area	32001
@NP	an SC/OEG graft	32013
@NP	cells considered likely to be OEG	32039
@NP	cells	32039
@NP	OEG	32069
@NP	They	32088
@NP	patches of basal lamina	32103
@NP	patches	32103
@NP	basal lamina	32114
@NP	processes	32140
@NP	clusters of axons	32171
@NP	clusters	32171
@NP	axons	32183
@NP	them	32210
@NP	SCs	32218
@NP	Fig. 3C	32226
@NP	These cells	32236
@NP	an area of central myelinated axons near the site of implantation	32267
@NP	an area	32267
@NP	central myelinated axons near the site of implantation	32278
@NP	central myelinated axons	32278
@NP	the site of implantation	32308
@NP	the site	32308
@NP	implantation	32320
@NP	SC-only grafts	32354
@NP	glia	32383
@NP	axonal sparing/regeneration	32408
@NP	The glial transplants	32436
@NP	immunostaining for p75 , the low-affinity nerve growth factor receptor ,	32480
@NP	immunostaining	32480
@NP	p75 , the low-affinity nerve growth factor receptor ,	32499
@NP	p75	32499
@NP	the low-affinity nerve growth factor receptor	32504
@NP	stains both SCs	32557
@NP	OEG	32577
@NP	control rats	32585
@NP	p75 immunoreactivity	32599
@NP	strands of tissue	32633
@NP	strands	32633
@NP	tissue	32644
@NP	the damaged area -LRB- Fig. 4A -RRB-	32658
@NP	the damaged area	32658
@NP	Fig. 4A	32676
@NP	animals	32689
@NP	an SC -LRB- Fig. 4B -RRB- , OEG -LRB- Fig. 4C -RRB- , or SC/OEG graft	32702
@NP	an SC -LRB- Fig. 4B -RRB-	32702
@NP	an SC	32702
@NP	Fig. 4B	32709
@NP	OEG -LRB- Fig. 4C -RRB-	32719
@NP	OEG	32719
@NP	Fig. 4C	32724
@NP	SC/OEG graft	32737
@NP	p75 immunoreactivity	32751
@NP	the transplanted area	32792
@NP	the p75 staining	32826
@NP	SC grafts	32882
@NP	OEG or SC/OEG grafts	32900
@NP	The presence of reactive astrocytes within the transplanted cord segment	32922
@NP	The presence	32922
@NP	reactive astrocytes within the transplanted cord segment	32938
@NP	reactive astrocytes	32938
@NP	the transplanted cord segment	32965
@NP	antibodies	33015
@NP	GFAP	33034
@NP	control animals	33043
@NP	a rim of GFAP staining along the surrounding spinal cord tissue	33060
@NP	a rim	33060
@NP	GFAP staining along the surrounding spinal cord tissue	33069
@NP	GFAP staining	33069
@NP	the surrounding spinal cord tissue	33089
@NP	the injury area	33135
@NP	GFAP staining	33163
@NP	the spinal cord surrounding the SC -LRB- Fig. 4D -RRB-	33197
@NP	the spinal cord	33197
@NP	the SC -LRB- Fig. 4D -RRB-	33225
@NP	the SC	33225
@NP	Fig. 4D	33233
@NP	OEG -LRB- Fig. 4E -RRB-	33243
@NP	OEG	33243
@NP	Fig. 4E	33248
@NP	SC/OEG grafts -LRB- Fig. 4F -RRB-	33262
@NP	SC/OEG grafts	33262
@NP	Fig. 4F	33277
@NP	Some GFAP reactivity	33287
@NP	the transplants	33325
@NP	GFAP staining	33353
@NP	SC-containing grafts -LRB- Fig. 4G , I -RRB-	33387
@NP	SC-containing grafts	33387
@NP	Fig. 4G	33409
@NP	I	33417
@NP	OEG grafts -LRB- Fig. 4H -RRB-	33429
@NP	OEG grafts	33429
@NP	Fig. 4H	33441
@NP	The presence	33451
@NP	chondroitin sulfate proteoglycan	33467
@NP	CSPG	33501
@NP	the grafted cord segment	33514
@NP	the CS-56 antibody	33557
@NP	control animals	33580
@NP	some CSPG staining	33597
@NP	the injury area	33633
@NP	All three types of glial grafts and the surrounding spinal tissue	33650
@NP	All three types	33650
@NP	glial grafts and the surrounding spinal tissue	33669
@NP	glial grafts	33669
@NP	the surrounding spinal tissue	33686
@NP	CSPG immunoreactivity	33726
@NP	SC grafts -LRB- Fig. 4J -RRB-	33760
@NP	SC grafts	33760
@NP	Fig. 4J	33771
@NP	more intense CSPG immunostaining	33790
@NP	OEG -LRB- Fig. 4K -RRB- or SC/OEG grafts -LRB- Fig. 4L -RRB-	33828
@NP	OEG	33828
@NP	Fig. 4K	33833
@NP	SC/OEG grafts	33845
@NP	Fig. 4L	33860
@NP	Intense neurofilament -LRB- Fig. 4M -RRB- and GAP-43 immunostaining	33870
@NP	Intense neurofilament -LRB- Fig. 4M -RRB-	33870
@NP	Intense neurofilament	33870
@NP	Fig. 4M	33893
@NP	GAP-43 immunostaining	33906
@NP	the presence of numerous axons	33940
@NP	the presence	33940
@NP	numerous axons	33956
@NP	SC -LRB- Martin et al. , 1991 , 1996 -RRB- , OEG , and SC/OEG grafts	33987
@NP	SC	33987
@NP	Martin	33991
@NP	et al. , 1991 , 1996	33998
@NP	et al.	33998
@NP	1991	34006
@NP	1996	34012
@NP	OEG	34019
@NP	SC/OEG grafts	34028
@NP	Different antibodies	34043
@NP	phenotypes of these axons	34085
@NP	phenotypes	34085
@NP	these axons	34099
@NP	Anti-CGRP antibodies	34112
@NP	sensory axons -LRB- Gibson et al. , 1984 -RRB-	34157
@NP	sensory axons	34157
@NP	Gibson	34172
@NP	et al. , 1984	34179
@NP	et al.	34179
@NP	1984	34187
@NP	the grafts -LRB- Fig. 4N -RRB-	34236
@NP	the grafts	34236
@NP	Fig. 4N	34248
@NP	CGRP-positive axons	34258
@NP	the surrounding white matter	34301
@NP	Anti-5-HT antibodies	34331
@NP	some serotonergic axons	34366
@NP	the raphe nuclei in the brainstem -LRB- Newton and Hamill , 1988 -RRB-	34396
@NP	the raphe nuclei	34396
@NP	the brainstem -LRB- Newton and Hamill , 1988 -RRB-	34416
@NP	the brainstem	34416
@NP	Newton and Hamill	34431
@NP	1988	34450
@NP	the grafts -LRB- Fig. 4O -RRB-	34472
@NP	the grafts	34472
@NP	Fig. 4O	34484
@NP	5-HT-positive axons	34494
@NP	the rostral gray matter	34535
@NP	the lateral white matter -LRB- Fig. 4O -RRB-	34566
@NP	the lateral white matter	34566
@NP	Fig. 4O	34592
@NP	Adrenergic axons	34602
@NP	locus ceruleus neurons	34649
@NP	anti-D Hantibodies -LRB- Newton and Hamill , 1988 -RRB-	34692
@NP	anti-D Hantibodies	34692
@NP	Newton and Hamill	34712
@NP	1988	34731
@NP	spared white matter but not in the transplants or beyond the distal interface	34752
@NP	spared white matter	34752
@NP	the transplants	34783
@NP	the distal interface	34809
@NP	These observations	34831
@NP	the transplants	34864
@NP	some sensory and serotonergic axons	34888
@NP	most of the axons	34929
@NP	most	34929
@NP	the axons	34937
@NP	spinal cord neurons	34972
@NP	More	34993
@NP	axons	34998
@NP	the lesion level with SC-containing than OEG grafts Retrograde	35023
@NP	the lesion level	35023
@NP	SC-containing than OEG grafts Retrograde	35045
@NP	OEG grafts	35064
@NP	neuronal	35086
@NP	analysis Axonal sparing/regeneration	35103
@NP	propriospinal and supraspinal projections	35143
@NP	retrograde FB	35204
@NP	Figure 5 , A and B ,	35236
@NP	Figure 5	35236
@NP	A and B	35246
@NP	representative examples	35261
@NP	FB-labeled neurons in the T8 -- 7 cord segment in control	35288
@NP	FB-labeled neurons in the T8	35288
@NP	FB-labeled neurons	35288
@NP	the T8	35310
@NP	7 cord segment in control	35317
@NP	7 cord segment	35317
@NP	control	35335
@NP	SC-grafted rats , respectively	35347
@NP	SC-grafted rats	35347
@NP	The number	35378
@NP	FB-labeled neurons	35392
@NP	the T8	35414
@NP	7 , T2 , C6 , and C2 cord segments in SC and SC/OEG transplanted animals	35421
@NP	7 , T2 , C6 , and C2 cord segments	35421
@NP	7 , T2 , C6 , and C2	35421
@NP	SC and SC/OEG transplanted animals	35456
@NP	SC	35456
@NP	SC/OEG transplanted animals	35463
@NP	OEG-only grafted animals	35503
@NP	p < 0.05	35556
@NP	p	35556
@NP	< 0.05	35558
@NP	<	35558
@NP	0.05	35560
@NP	controls -LRB- Fig. 5C -RRB-	35574
@NP	controls	35574
@NP	Fig. 5C	35584
@NP	Figure 5 , D and E ,	35594
@NP	Figure 5	35594
@NP	D and E	35604
@NP	FB-labeled cells	35626
@NP	the reticular formation of control and SC/OEG-grafted animals	35650
@NP	the reticular formation	35650
@NP	control and SC/OEG-grafted animals	35677
@NP	the brainstem	35734
@NP	the total number of FB-labeled neurons	35749
@NP	the total number	35749
@NP	FB-labeled neurons	35769
@NP	p < 0.05	35815
@NP	p	35815
@NP	< 0.05	35817
@NP	<	35817
@NP	0.05	35819
@NP	animals receiving SC or SC/OEG	35828
@NP	animals	35828
@NP	SC or SC/OEG	35846
@NP	OEG , grafts compared with controls -LRB- Fig. 5F -RRB-	35868
@NP	OEG	35868
@NP	grafts compared with controls -LRB- Fig. 5F -RRB-	35873
@NP	grafts	35873
@NP	controls -LRB- Fig. 5F -RRB-	35894
@NP	controls	35894
@NP	Fig. 5F	35904
@NP	FB-labeled neurons	35923
@NP	the cerebral cortex of control -LRB- Fig. 5G -RRB-	35965
@NP	the cerebral cortex	35965
@NP	control -LRB- Fig. 5G -RRB-	35988
@NP	control	35988
@NP	Fig. 5G	35997
@NP	-LRB- Fig. 5H -RRB- animals	36018
@NP	Fig. 5H	36019
@NP	no significant difference	36037
@NP	the total number of FB-labeled neurons	36076
@NP	the total number	36076
@NP	FB-labeled neurons	36096
@NP	any of the groups -LRB- Fig. 5I -RRB-	36118
@NP	any	36118
@NP	the groups -LRB- Fig. 5I -RRB-	36125
@NP	the groups	36125
@NP	Fig. 5I	36137
@NP	These results	36148
@NP	SC and SC/OEG grafts but not OEG grafts	36176
@NP	SC and SC/OEG grafts	36176
@NP	OEG grafts	36205
@NP	a 1 week moderately contused thoracic spinal cord	36230
@NP	a 1 week	36230
@NP	thoracic spinal cord	36259
@NP	the sparing / regeneration of propriospinal and supraspinal axons	36288
@NP	the sparing	36288
@NP	regeneration	36301
@NP	propriospinal and supraspinal axons	36317
@NP	None of the grafts	36354
@NP	None	36354
@NP	the grafts	36362
@NP	this measure	36385
@NP	sparing/regeneration of corticospinal axons	36408
@NP	sparing/regeneration	36408
@NP	corticospinal axons	36432
@NP	Anterograde	36453
@NP	analysis	36480
@NP	The presence of corticospinal axons in the grafted area	36489
@NP	The presence	36489
@NP	corticospinal axons in the grafted area	36505
@NP	corticospinal axons	36505
@NP	the grafted area	36528
@NP	anterograde	36565
@NP	12 weeks after injury	36596
@NP	12 weeks	36596
@NP	injury	36611
@NP	most of the corticospinal axons	36619
@NP	most	36619
@NP	the corticospinal axons	36627
@NP	present rostral	36656
@NP	the grafted area	36675
@NP	axonal end bulbs	36707
@NP	ongoing degeneration -LRB- Tator , 1995 -RRB-	36736
@NP	ongoing degeneration	36736
@NP	Tator	36758
@NP	1995	36765
@NP	all groups	36775
@NP	corticospinal axons	36787
@NP	thin sprouts	36820
@NP	the nearby gray matter	36838
@NP	the transplants -LRB- Fig. 6A -RRB-	36870
@NP	the transplants	36870
@NP	Fig. 6A	36887
@NP	Quantification	36897
@NP	a significantly higher number of corticospinal sprouts	36926
@NP	a significantly higher number	36926
@NP	corticospinal sprouts	36959
@NP	2 mm rostral	36996
@NP	the lesion epicenter	37012
@NP	grafted animals compared with control animals -LRB- Fig. 6B -RRB-	37036
@NP	grafted animals	37036
@NP	control animals -LRB- Fig. 6B -RRB-	37066
@NP	control animals	37066
@NP	Fig. 6B	37083
@NP	The numbers found at 1 mm rostral to the epicenter and at the epicenter	37093
@NP	The numbers	37093
@NP	1 mm rostral to the epicenter and at the epicenter	37114
@NP	1 mm rostral	37114
@NP	the epicenter	37130
@NP	the epicenter	37151
@NP	groups -LRB- Fig. 6B -RRB-	37202
@NP	groups	37202
@NP	Fig. 6B	37210
@NP	Axonal sparing/regeneration of reticulospinal and vestibulospinal fibers	37220
@NP	Axonal sparing/regeneration	37220
@NP	reticulospinal and vestibulospinal fibers	37251
@NP	anterograde	37312
@NP	control and grafted rats	37343
@NP	control	37343
@NP	grafted rats	37355
@NP	reticulospinal -LRB- Fig. 6C -RRB- and vestibulospinal -LRB- Fig. 6D -RRB- axons	37369
@NP	reticulospinal -LRB- Fig. 6C -RRB-	37369
@NP	reticulospinal	37369
@NP	Fig. 6C	37385
@NP	vestibulospinal -LRB- Fig. 6D -RRB- axons	37398
@NP	Fig. 6D	37415
@NP	the peripheral spinal white matter	37447
@NP	the grafts	37496
@NP	Transplantation of SC or SC/OEG 1 week after moderate contusion	37508
@NP	Transplantation	37508
@NP	SC or SC/OEG 1 week after moderate contusion	37527
@NP	SC or SC/OEG	37527
@NP	1 week	37540
@NP	moderate contusion	37553
@NP	hindlimb performance	37581
@NP	All animals	37602
@NP	a gradual improvement	37624
@NP	hindlimb locomotor function during the 11 week period	37649
@NP	hindlimb locomotor function	37649
@NP	the 11 week period	37684
@NP	cell transplantation -LRB- Fig. 7 -RRB-	37709
@NP	cell transplantation	37709
@NP	Fig. 7	37731
@NP	all experimental groups	37743
@NP	most rats	37768
@NP	a BBB score of 10 -- 11	37791
@NP	a BBB score of 10	37791
@NP	a BBB score	37791
@NP	10	37806
@NP	11	37809
@NP	they	37813
@NP	occasional -LRB- 10 -RRB-	37828
@NP	occasional	37828
@NP	10	37840
@NP	frequent to consistent -LRB- 11 -RRB- weight-supported	37847
@NP	11	37871
@NP	plantar	37892
@NP	consistent weight-supported plantar	37922
@NP	occasional	37972
@NP	frequent forelimb	37986
@NP	BBB score of 12	38027
@NP	BBB score	38027
@NP	12	38040
@NP	SC-only grafted animals	38065
@NP	Statistical analysis	38090
@NP	the open field locomotor scores	38126
@NP	the SCtransplanted group	38161
@NP	8 , 9 , 10 , and 11 weeks after injury and of SC/OEG at 8 weeks after injury	38189
@NP	8	38189
@NP	9	38192
@NP	10	38195
@NP	11 weeks after injury and of SC/OEG at 8 weeks after injury	38203
@NP	11 weeks	38203
@NP	injury	38218
@NP	SC/OEG at 8 weeks after injury	38232
@NP	SC/OEG	38232
@NP	8 weeks after injury	38242
@NP	8 weeks	38242
@NP	injury	38256
@NP	p < 0.05	38291
@NP	p	38291
@NP	< 0.05	38293
@NP	<	38293
@NP	0.05	38295
@NP	the control group	38306
@NP	DISCUSSION	38326
@NP	The axonal growth-promoting effects of SCs -LRB- for review ,	38337
@NP	The axonal growth-promoting effects	38337
@NP	SCs -LRB- for review ,	38376
@NP	SCs	38376
@NP	review	38385
@NP	Bunge , 2001 ; Plant et al. , 2001 -RRB- and OEG	38397
@NP	Bunge	38397
@NP	2001 ; Plant et al. , 2001 -RRB-	38404
@NP	2001	38404
@NP	Plant et al. , 2001 -RRB-	38410
@NP	Plant	38410
@NP	et al.	38416
@NP	2001	38424
@NP	OEG	38434
@NP	review	38443
@NP	Franklin	38455
@NP	Barnett , 2000	38468
@NP	Barnett	38468
@NP	2000	38477
@NP	Kleitman and Bunge , 2000	38483
@NP	Kleitman and Bunge	38483
@NP	2000	38503
@NP	Ramo ' n-Cueto , 2000	38509
@NP	Ramo ' n-Cueto	38509
@NP	Ramo '	38509
@NP	2000	38523
@NP	Plant et al. , 2001	38529
@NP	Plant	38529
@NP	et al. , 2001	38535
@NP	et al.	38535
@NP	2001	38543
@NP	Raisman , 2001	38549
@NP	Raisman	38549
@NP	2001	38558
@NP	different adult rat spinal cord injury models	38585
@NP	we	38638
@NP	the restorative abilities	38672
@NP	SC and OEG transplants	38701
@NP	a 1-week-old moderate contusion lesion in the adult rat	38737
@NP	a 1-week-old moderate contusion lesion	38737
@NP	the adult rat	38779
@NP	thoracic spinal cord	38793
@NP	12 weeks after injury	38817
@NP	12 weeks	38817
@NP	injury	38832
@NP	All grafts	38840
@NP	injury-induced cavitation	38862
@NP	The results	38889
@NP	a SC graft	38915
@NP	spinal tissue sparing	38957
@NP	SC-containing grafts	38983
@NP	sparing/regeneration of spinal and supraspinal axons	39036
@NP	sparing/regeneration	39036
@NP	spinal and supraspinal axons	39060
@NP	an OEG graft	39094
@NP	All grafts	39108
@NP	axonal growth	39128
@NP	SC grafts	39147
@NP	the greatest number of myelinated axons	39167
@NP	the greatest number	39167
@NP	myelinated axons	39190
@NP	an SC graft	39223
@NP	an OEG graft	39248
@NP	hindlimb performance of the contused rats	39262
@NP	hindlimb performance	39262
@NP	the contused rats	39286
@NP	8 weeks	39331
@NP	transplantation	39345
@NP	Retrograde neuronal tracing	39362
@NP	Retrograde	39362
@NP	SC and SC/OEG grafts	39413
@NP	OEG-only grafts , more propriospinal and brainstem neurons	39448
@NP	OEG-only grafts	39448
@NP	more propriospinal and brainstem neurons	39465
@NP	the graft	39526
@NP	We	39537
@NP	axonal sparing	39580
@NP	injury-induced axonal dieback , or axonal regeneration ,	39610
@NP	injury-induced axonal dieback	39610
@NP	axonal regeneration	39644
@NP	both	39668
@NP	some regeneration	39685
@NP	axons	39724
@NP	the lesion epicenter	39746
@NP	the glia	39773
@NP	1 week	39800
@NP	injury	39813
@NP	a contusion injury	39835
@NP	the corticospinal tract -LRB- Hill et al. , 2001 -RRB-	39876
@NP	the corticospinal tract	39876
@NP	Hill	39901
@NP	et al. , 2001	39906
@NP	et al.	39906
@NP	2001	39914
@NP	the presence of corticospinal tract fibers in the graft	39921
@NP	the presence	39921
@NP	corticospinal tract fibers in the graft	39937
@NP	corticospinal tract fibers	39937
@NP	the graft	39967
@NP	regeneration	39985
@NP	the caveat	40004
@NP	there	40020
@NP	lateral and ventral corticospinal fibers	40057
@NP	All three types of implants	40099
@NP	All three types	40099
@NP	implants	40118
@NP	spinal tissue sparing at 12 weeks after injury	40149
@NP	spinal tissue	40149
@NP	12 weeks	40174
@NP	injury	40189
@NP	The SC graft	40197
@NP	spinal tissue damage	40251
@NP	the SC/OEG or OEG-only graft	40277
@NP	the SC/OEG	40277
@NP	OEG-only graft	40291
@NP	SC-induced tissue sparing	40307
@NP	less damage	40349
@NP	spinal white matter	40364
@NP	the presence of more propriospinal and brainstem projections distal to the graft	40405
@NP	the presence	40405
@NP	more propriospinal and brainstem projections distal to the graft	40421
@NP	more propriospinal and brainstem projections	40421
@NP	the graft	40476
@NP	SCs	40487
@NP	various growth factors	40499
@NP	nerve growth factor -LRB- Bandtlow et al. , 1987 -RRB-	40530
@NP	nerve growth factor	40530
@NP	Bandtlow	40551
@NP	et al. , 1987	40560
@NP	et al.	40560
@NP	1987	40568
@NP	brain-derived neurotrophic factor	40575
@NP	Acheson	40610
@NP	et al. , 1991 ; Meyer et al. , 1992	40618
@NP	et al.	40618
@NP	1991 ; Meyer et al.	40626
@NP	1991	40626
@NP	Meyer et al.	40632
@NP	Meyer	40632
@NP	et al.	40638
@NP	1992	40646
@NP	ciliary neurotrophic factor	40653
@NP	Friedman et al. , 1992 ; Meyer et al. , 1992 ; Rende et al. , 1992	40682
@NP	Friedman	40682
@NP	et al. , 1992 ; Meyer et al. , 1992 ; Rende et al. , 1992	40691
@NP	et al. , 1992	40691
@NP	et al.	40691
@NP	1992	40699
@NP	Meyer et al. , 1992	40705
@NP	Meyer	40705
@NP	et al. , 1992	40711
@NP	et al.	40711
@NP	1992	40719
@NP	Rende et al. , 1992	40725
@NP	Rende	40725
@NP	et al. , 1992	40731
@NP	et al.	40731
@NP	1992	40739
@NP	glial cell line-derived neurotrophic factor -LRB- Widenfalk et al. , 2001 -RRB-	40750
@NP	glial cell	40750
@NP	line-derived neurotrophic factor -LRB- Widenfalk et al. , 2001 -RRB-	40761
@NP	line-derived neurotrophic factor	40761
@NP	Widenfalk	40795
@NP	et al. , 2001	40805
@NP	et al.	40805
@NP	2001	40813
@NP	OEG share many properties	40829
@NP	SCs	40860
@NP	they	40865
@NP	a distinct cell type -LRB- Lakatos et al. , 2000 -RRB-	40889
@NP	a distinct cell type	40889
@NP	Lakatos	40911
@NP	et al. , 2000	40919
@NP	et al.	40919
@NP	2000	40927
@NP	convincing evidence	40946
@NP	OEG harvested from the adult olfactory bulb	40971
@NP	OEG	40971
@NP	the adult olfactory bulb	40990
@NP	neurotrophic factors	41023
@NP	Ramo ' n - Cueto and Avila , 1998 ; Kleitman and Bunge , 2000	41055
@NP	Ramo ' n - Cueto and Avila	41055
@NP	Ramo ' n	41055
@NP	Ramo '	41055
@NP	Cueto and Avila	41063
@NP	Cueto	41063
@NP	Avila	41073
@NP	1998 ; Kleitman	41080
@NP	1998	41080
@NP	Kleitman	41086
@NP	Bunge , 2000	41099
@NP	Bunge	41099
@NP	2000	41106
@NP	reports	41122
@NP	the production of neurotrophic factors	41147
@NP	the production	41147
@NP	neurotrophic factors	41165
@NP	OEG	41189
@NP	review	41198
@NP	Kleitman and Bunge , 2000	41210
@NP	Kleitman and Bunge	41210
@NP	2000	41230
@NP	it	41237
@NP	these cells	41258
@NP	several factors	41278
@NP	their receptors -LRB- Boruch et al. , 2001 ; Woodhall et al. , 2001 -RRB-	41298
@NP	their receptors	41298
@NP	Boruch	41315
@NP	et al. , 2001 ; Woodhall et al. , 2001	41322
@NP	et al.	41322
@NP	2001 ; Woodhall et al.	41330
@NP	2001	41330
@NP	Woodhall et al.	41336
@NP	Woodhall	41336
@NP	et al.	41345
@NP	2001	41353
@NP	We	41360
@NP	the present experiment	41381
@NP	SCs	41405
@NP	more supportive factors	41418
@NP	OEG , which may have caused the observed difference in tissue sparing	41447
@NP	OEG	41447
@NP	the observed difference in tissue sparing	41474
@NP	the observed difference	41474
@NP	tissue sparing	41501
@NP	The secretion of various axonal growth-promoting factors	41517
@NP	The secretion	41517
@NP	various axonal growth-promoting factors	41534
@NP	the SC	41583
@NP	a widely used successful cellular substrate	41590
@NP	repair strategies	41638
@NP	the adult spinal cord	41659
@NP	Martin	41682
@NP	et al.	41689
@NP	1991 , 1996	41697
@NP	1991	41697
@NP	1996	41703
@NP	Paino et al. , 1994	41709
@NP	Paino	41709
@NP	et al. , 1994	41715
@NP	et al.	41715
@NP	1994	41723
@NP	Xu et al. , 1995a , b , 1997 , 1999	41729
@NP	Xu	41729
@NP	et al. , 1995a , b , 1997 , 1999	41732
@NP	et al.	41732
@NP	1995a	41740
@NP	b	41746
@NP	1997	41749
@NP	1999	41755
@NP	Chen et al. , 1996	41761
@NP	Chen	41761
@NP	et al. , 1996	41766
@NP	et al.	41766
@NP	1996	41774
@NP	Montgomery et al. , 1996	41780
@NP	Montgomery	41780
@NP	et al. , 1996	41791
@NP	et al.	41791
@NP	1996	41799
@NP	Guest et al. , 1997	41805
@NP	Guest	41805
@NP	et al. , 1997	41811
@NP	et al.	41811
@NP	1997	41819
@NP	Oudega et al.	41825
@NP	Oudega	41825
@NP	et al.	41832
@NP	1997	41840
@NP	OEG	41847
@NP	regeneration	41883
@NP	different injury models	41899
@NP	the adult rat spinal cord	41926
@NP	Ramo ' n-Cueto and Nieto-Sampedro , 1994 ; Li et al.	41953
@NP	Ramo ' n-Cueto	41953
@NP	Ramo '	41953
@NP	Nieto-Sampedro , 1994	41970
@NP	Nieto-Sampedro	41970
@NP	1994	41986
@NP	Li et al.	41992
@NP	Li	41992
@NP	et al.	41995
@NP	1997 , 1998 ; Ramo ' n-Cueto et al.	42003
@NP	1997 , 1998	42003
@NP	1997	42003
@NP	1998	42009
@NP	Ramo ' n-Cueto et al.	42015
@NP	Ramo ' n-Cueto	42015
@NP	Ramo '	42015
@NP	et al.	42028
@NP	1998 , 2000	42036
@NP	1998	42036
@NP	2000	42042
@NP	OEG	42054
@NP	the cord	42071
@NP	a transection -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	42087
@NP	a transection	42087
@NP	Ramo ' n-Cueto et al. , 2000	42102
@NP	Ramo ' n-Cueto et al.	42102
@NP	Ramo ' n-Cueto	42102
@NP	Ramo '	42102
@NP	et al.	42115
@NP	2000	42123
@NP	a transection filled with an SC graft -LRB- Ramo ' n-Cueto et al. , 1998 -RRB-	42132
@NP	a transection	42132
@NP	an SC graft -LRB- Ramo ' n-Cueto et al. , 1998 -RRB-	42158
@NP	an SC graft	42158
@NP	Ramo ' n-Cueto et al. , 1998	42171
@NP	Ramo ' n-Cueto et al.	42171
@NP	Ramo ' n-Cueto	42171
@NP	Ramo '	42171
@NP	1998	42192
@NP	axons	42199
@NP	the injury site	42225
@NP	the spinal cord	42255
@NP	This finding	42272
@NP	the ability of OEG	42303
@NP	the ability	42303
@NP	OEG	42318
@NP	the injury site	42343
@NP	the spinal nervous tissue	42364
@NP	SCs	42391
@NP	such migratory ability	42407
@NP	Xu et al. , 1995a , 1997 ; Iwashita et al. , 2000	42431
@NP	Xu	42431
@NP	et al. , 1995a , 1997 ; Iwashita et al. , 2000	42434
@NP	et al.	42434
@NP	1995a	42442
@NP	1997 ; Iwashita et al.	42449
@NP	1997	42449
@NP	Iwashita et al.	42455
@NP	Iwashita	42455
@NP	et al.	42464
@NP	2000	42472
@NP	our transplantation model	42482
@NP	the SCs and OEG	42509
@NP	a 1 week moderate contusion injury	42544
@NP	Ongoing cytotoxic processes within the contusion environment	42580
@NP	Ongoing cytotoxic processes	42580
@NP	the contusion environment	42615
@NP	the grafted cells	42659
@NP	These processes	42678
@NP	excitotoxic , inflammatory , proteolytic , and anoxic events	42702
@NP	all components	42771
@NP	progressive secondary injury	42789
@NP	Tator and Fehlings , 1991 ; Anderson and Hall , 1993 ; Amar and Levy , 1999	42819
@NP	Tator and Fehlings	42819
@NP	1991 ; Anderson and Hall , 1993 ; Amar and Levy	42839
@NP	1991	42839
@NP	Anderson and Hall , 1993 ; Amar and Levy	42845
@NP	Anderson and Hall	42845
@NP	1993	42864
@NP	Amar	42870
@NP	Levy	42879
@NP	1999	42885
@NP	Our results	42892
@NP	OEG	42917
@NP	these cytotoxic events	42955
@NP	SCs	42983
@NP	We	42988
@NP	survival of OEG	43015
@NP	survival	43015
@NP	OEG	43027
@NP	morphological means	43034
@NP	the difficulty in definitively identifying OEG without a specific label	43065
@NP	the difficulty	43065
@NP	OEG	43108
@NP	a specific label	43120
@NP	Both SCs and OEG	43138
@NP	Both SCs	43138
@NP	OEG	43151
@NP	p75 antibody	43170
@NP	OEG	43184
@NP	SCs	43227
@NP	they	43236
@NP	axons	43253
@NP	cord -LRB- Imaizumi et al. , 1998 , 2000 -RRB-	43275
@NP	cord	43275
@NP	Imaizumi	43281
@NP	et al. , 1998 , 2000	43290
@NP	et al.	43290
@NP	1998	43298
@NP	2000	43304
@NP	We	43311
@NP	only a few cells	43320
@NP	OEG	43365
@NP	the basis	43372
@NP	the pattern of ensheathment of axon bundles observed in the electron microscope	43385
@NP	the pattern	43385
@NP	ensheathment of axon bundles observed in the electron microscope	43400
@NP	ensheathment	43400
@NP	axon bundles observed in the electron microscope	43416
@NP	axon bundles	43416
@NP	the electron microscope	43441
@NP	12 weeks after injury	43469
@NP	12 weeks	43469
@NP	injury	43484
@NP	SC transplants	43492
@NP	better continuity with the spinal tissue	43525
@NP	better continuity	43525
@NP	the spinal tissue	43548
@NP	OEG transplants	43571
@NP	These observations	43588
@NP	SC transplants	43623
@NP	injury-induced tissue damage	43670
@NP	axonal sparing/regeneration	43713
@NP	an OEG transplant	43774
@NP	it	43799
@NP	mind	43820
@NP	the SC graft	43830
@NP	twice as many SCs	43853
@NP	the SC/OEG graft	43874
@NP	It	43892
@NP	the axons with peripheraltype myelin in the transplant area	43930
@NP	the axons	43930
@NP	peripheraltype myelin in the transplant area	43945
@NP	the transplant	43970
@NP	SCs or OEG	44009
@NP	Axons with peripheral myelin	44021
@NP	Axons	44021
@NP	peripheral myelin	44032
@NP	the nontransplanted animals in this study	44064
@NP	the nontransplanted animals	44064
@NP	this study	44095
@NP	several previous studies conducted in our laboratory	44120
@NP	several previous studies	44120
@NP	our laboratory	44158
@NP	others , showing that SCs migrate into lesion areas and myelinate axons there	44184
@NP	others	44184
@NP	SCs	44205
@NP	lesion areas and myelinate axons	44222
@NP	lesion areas	44222
@NP	myelinate axons	44239
@NP	SC/OEG transplants	44265
@NP	cells located in areas of central-type myelin near the implantation site	44285
@NP	cells	44285
@NP	areas of central-type myelin near the implantation site	44302
@NP	areas	44302
@NP	central-type myelin near the implantation site	44311
@NP	the implantation	44336
@NP	patches of basal lamina	44368
@NP	patches	44368
@NP	basal lamina	44379
@NP	processes	44405
@NP	clusters of axons	44436
@NP	clusters	44436
@NP	axons	44448
@NP	them	44475
@NP	SCs	44483
@NP	Fig. 3C	44501
@NP	This type of ensheathment	44511
@NP	This type	44511
@NP	ensheathment	44524
@NP	that of OEG in vivo	44560
@NP	that	44560
@NP	OEG in vivo	44568
@NP	OEG	44568
@NP	vivo	44575
@NP	review , see Kleitman and Bunge , 2000	44585
@NP	review	44585
@NP	see Kleitman and Bunge , 2000	44593
@NP	Kleitman and Bunge , 2000	44597
@NP	Kleitman and Bunge	44597
@NP	2000	44617
@NP	these cells	44634
@NP	OEG that migrated into spinal tissue	44650
@NP	OEG	44650
@NP	spinal tissue	44673
@NP	Many papers	44688
@NP	myelination	44714
@NP	OEG in vivo	44729
@NP	OEG	44729
@NP	vivo	44736
@NP	Franklin	44742
@NP	et al. , 1996	44751
@NP	et al.	44751
@NP	1996	44759
@NP	Li et al. , 1997 , 1998	44765
@NP	Li	44765
@NP	et al. , 1997 , 1998	44768
@NP	et al.	44768
@NP	1997	44776
@NP	1998	44782
@NP	Imaizumi et al. , 1998 , 2000	44788
@NP	Imaizumi	44788
@NP	et al. , 1998 , 2000	44797
@NP	et al.	44797
@NP	1998	44805
@NP	2000	44811
@NP	Barnett et al. , 2000	44817
@NP	Barnett	44817
@NP	et al. , 2000	44825
@NP	et al.	44825
@NP	2000	44833
@NP	Kato et al. , 2000	44839
@NP	Kato	44839
@NP	et al. , 2000	44844
@NP	et al.	44844
@NP	2000	44852
@NP	less myelin	44869
@NP	less	44869
@NP	OEG transplants in our study	44895
@NP	OEG transplants	44895
@NP	our study	44914
@NP	the environment of the contusion cavity	44932
@NP	the environment	44932
@NP	the contusion cavity	44951
@NP	them	44984
@NP	a recent study from our laboratory	44999
@NP	a recent study	44999
@NP	our laboratory	45019
@NP	OEG	45049
@NP	myelin under the same culture conditions	45065
@NP	the same culture	45078
@NP	SC myelination	45129
@NP	Plant , Cuervo , Bates , Bunge , and Wood , unpublished observations	45145
@NP	Plant	45145
@NP	Cuervo	45152
@NP	Bates	45160
@NP	Bunge	45167
@NP	Wood , unpublished observations	45178
@NP	Wood	45178
@NP	unpublished observations	45184
@NP	future studies	45214
@NP	transplantation of labeled OEG	45230
@NP	transplantation	45230
@NP	labeled OEG	45249
@NP	the ability of OEG	45280
@NP	the ability	45280
@NP	OEG	45295
@NP	Both types of SC-containing grafts	45318
@NP	Both types	45318
@NP	SC-containing grafts	45332
@NP	hindlimb function	45362
@NP	the SC-only graft	45385
@NP	the only group	45407
@NP	controls	45462
@NP	This finding	45472
@NP	agreement with our observation	45491
@NP	agreement	45491
@NP	our observation	45506
@NP	SC grafts	45527
@NP	a higher number of spinal and supraspinal axons	45549
@NP	a higher number	45549
@NP	spinal and supraspinal axons	45568
@NP	spinal segments	45606
@NP	the grafted area compared with OEG grafts	45632
@NP	the grafted area	45632
@NP	OEG grafts	45663
@NP	It	45675
@NP	hindlimb recovery after an incomplete SCI	45704
@NP	hindlimb recovery	45704
@NP	an incomplete SCI	45728
@NP	the number	45757
@NP	axons	45805
@NP	brainstem nuclei and cerebral cortex	45816
@NP	brainstem nuclei	45816
@NP	cerebral cortex	45837
@NP	Saruhashi and Young , 1994 ; Basso et al. , 1996	45854
@NP	Saruhashi and Young	45854
@NP	1994 ; Basso et al.	45875
@NP	1994	45875
@NP	Basso et al.	45881
@NP	Basso	45881
@NP	et al.	45887
@NP	1996	45895
@NP	local propriospinal axons	45910
@NP	Goldberger , 1988a	45937
@NP	Goldberger	45937
@NP	1988a	45949
@NP	b ; Helgren and Goldberger , 1993	45955
@NP	b	45955
@NP	Helgren and Goldberger , 1993	45958
@NP	Helgren and Goldberger	45958
@NP	1993	45982
@NP	it	46004
@NP	only a small percentage of the descending brainstem axons	46020
@NP	only a small percentage	46020
@NP	the descending brainstem axons	46047
@NP	the segmental circuits	46097
@NP	the generation	46132
@NP	basic locomotion patterns	46150
@NP	Helgren and Goldberger , 1993 ; Basso et al. , 1996 ; Ribotta et al. , 2000	46177
@NP	Helgren and Goldberger	46177
@NP	Helgren	46177
@NP	Goldberger	46189
@NP	1993 ; Basso et al.	46201
@NP	1993	46201
@NP	Basso et al.	46207
@NP	Basso	46207
@NP	et al.	46213
@NP	1996 ; Ribotta et al. , 2000	46221
@NP	1996	46221
@NP	Ribotta et al. , 2000	46227
@NP	Ribotta	46227
@NP	et al. , 2000	46235
@NP	et al.	46235
@NP	2000	46243
@NP	the increased sparing of tissue seen in the present study	46255
@NP	the increased sparing	46255
@NP	tissue seen in the present study	46280
@NP	tissue	46280
@NP	the present study	46295
@NP	the observed improvement in functional recovery	46327
@NP	the observed improvement	46327
@NP	functional recovery	46355
@NP	the improvement in behavioral outcome	46391
@NP	the improvement	46391
@NP	behavioral outcome	46410
@NP	part	46463
@NP	remyelination of spared axons by the transplanted SCs	46472
@NP	remyelination	46472
@NP	spared axons by the transplanted SCs	46489
@NP	spared axons	46489
@NP	the transplanted SCs	46505
@NP	It	46527
@NP	functional recovery seen in rats transplanted with embryonic stem cells	46560
@NP	functional recovery	46560
@NP	rats transplanted with embryonic stem cells	46588
@NP	rats	46588
@NP	embryonic stem cells	46611
@NP	remyelination of axons	46646
@NP	remyelination	46646
@NP	axons	46663
@NP	oligodendrocytes	46672
@NP	the grafted stem cells -LRB- McDonald et al. , 1999 -RRB-	46703
@NP	the grafted stem cells	46703
@NP	McDonald	46727
@NP	et al. , 1999	46736
@NP	et al.	46736
@NP	1999	46744
@NP	the present study	46754
@NP	it	46773
@NP	this question	46804
@NP	the transplanted cells	46826
@NP	the cells	46878
@NP	it	46909
@NP	the myelinated axon	46953
@NP	Both SCs and OEG	46999
@NP	Both SCs	46999
@NP	OEG	47012
@NP	important candidates for future cell transplantation strategies	47032
@NP	important candidates	47032
@NP	future cell transplantation strategies	47057
@NP	the injured adult spinal cord	47099
@NP	their axonal growth-promoting and myelinating properties	47140
@NP	The present study	47198
@NP	these cell types	47234
@NP	combination	47271
@NP	SC grafts	47298
@NP	the greatest effect on protecting contused spinal tissue	47313
@NP	the greatest effect	47313
@NP	contused spinal tissue	47347
@NP	Another clinically relevant advantage	47371
@NP	SCs	47417
@NP	a spinal cord	47442
@NP	person 's peripheral nerve	47464
@NP	person 's	47464
@NP	very large numbers	47506
@NP	culture	47528
@NP	autologous transplantation	47555
@NP	the injured human cord	47587
@NP	A potential limitation of SC grafts	47611
@NP	A potential limitation	47611
@NP	SC grafts	47637
@NP	they	47655
@NP	reentry of axons	47675
@NP	reentry	47675
@NP	axons	47686
@NP	the spinal cord	47697
@NP	axonal circuits that are involved in locomotion	47752
@NP	axonal circuits	47752
@NP	locomotion	47789
@NP	OEG	47801
@NP	promise	47816
@NP	such reentry	47837
@NP	we	47855
@NP	they	47873
@NP	axonal growth and myelination	47913
@NP	SCs	47948
@NP	the contusion lesion	47975
@NP	An alternative approach	47997
@NP	advantage of the regenerationpromoting characteristics of both cell types	48037
@NP	advantage	48037
@NP	the regenerationpromoting characteristics of both cell types	48050
@NP	the regenerationpromoting characteristics	48050
@NP	both cell types	48095
@NP	graft SC	48117
@NP	the contusion lesion and OEG	48131
@NP	the contusion lesion	48131
@NP	OEG	48156
@NP	the adjacent spinal tissue	48165
@NP	The restorative ability	48193
@NP	this combination strategy	48220
@NP	axonal regeneration/sparing	48259
@NP	hindlimb function	48301
@NP	our laboratory	48354
@VP	to Cure Paralysis	358
@VP	Cure Paralysis	361
@VP	suspended in culture medium or culture medium only -LRB- controls -RRB-	781
@VP	exhibited diminished cavitation	890
@VP	diminished cavitation	900
@VP	centered at the injury site	1012
@VP	was spared	1040
@VP	spared	1044
@VP	grafted animals	1130
@VP	were filled with axons , primarily of spinal origin	1179
@VP	filled with axons , primarily of spinal origin	1184
@VP	contained more myelinated axons than SC/OEG and OEG grafts	1241
@VP	tracing	1483
@VP	reaching 5 -- 6 mm beyond the grafted area	1557
@VP	grafted animals than in controls	1771
@VP	was detected at 8 -- 11 weeks after injury	1911
@VP	detected at 8 -- 11 weeks after injury	1915
@VP	contused adult rat thoracic	2141
@VP	causes permanent functional deficits	2269
@VP	see Amar and Levy , 1999	2319
@VP	are still observed	2661
@VP	observed	2671
@VP	has very poor clinical prospects	2731
@VP	promoting axonal sparing / regeneration and restoring functional deficits	2798
@VP	promoting axonal sparing / regeneration	2798
@VP	sparing	2815
@VP	restoring functional deficits	2841
@VP	suggest that there may be a window of opportunity for repair after SCI	2871
@VP	may be a window of opportunity for repair after SCI	2890
@VP	be a window of opportunity for repair after SCI	2894
@VP	see Bunge , 2001 ; Jones et al. , 2001	2955
@VP	see Bunge , 1994 ; Bunge and Kleitman , 1999	3446
@VP	bridging a transected adult rat	3502
@VP	promotes axonal regeneration from brainstem neurons as well	3791
@VP	has shown promise in SCI repair	3876
@VP	shown promise in SCI repair	3880
@VP	is olfactory ensheathing glia -LRB- OEG -RRB-	3908
@VP	combining an SC graft with OEG placed into the transected cord stumps	4224
@VP	placed into the transected cord stumps	4255
@VP	transected cord stumps	4271
@VP	descending and ascending axons into the caudal and rostral cord , respectively	4319
@VP	see Blakemore et al. , 2000	4677
@VP	see also Imaizumi et al. , 1998 , 2000	4706
@VP	is a contusive injury -LRB- Bunge et al. , 1997 ; Kakulas , 1999 -RRB-	4803
@VP	are sparse	4976
@VP	were assessed in moderately contused adult Fischer rat thoracic spinal cord	5147
@VP	assessed in moderately contused adult Fischer rat thoracic spinal cord	5152
@VP	contused adult Fischer rat thoracic	5175
@VP	spared and regenerated axons	5286
@VP	spared	5286
@VP	regenerated axons	5297
@VP	could not be distinguished	5315
@VP	be distinguished	5325
@VP	distinguished	5328
@VP	described previously	5669
@VP	To determine the purity of the SCs used for grafting	5716
@VP	determine the purity of the SCs used for grafting	5719
@VP	used for grafting	5751
@VP	grafting	5760
@VP	plated onto culture dishes	5804
@VP	cultured for 3 hr	5832
@VP	stained for S100	5851
@VP	containing 100 µM Hoechst nuclear dye -LRB- Sigma , St.	5953
@VP	dye	5987
@VP	to compare numbers of S100-positive cells with Hoechst-labeled cells	6014
@VP	compare numbers of S100-positive cells with Hoechst-labeled cells	6017
@VP	used for implantation	6106
@VP	was 95 -- 98 %	6128
@VP	described previously	6308
@VP	was taken to minimize the inclusion of non-nerve fiber layer bulb tissue	6363
@VP	taken to minimize the inclusion of non-nerve fiber layer bulb tissue	6367
@VP	to minimize the inclusion of non-nerve fiber layer bulb tissue	6373
@VP	minimize the inclusion of non-nerve fiber layer bulb tissue	6376
@VP	was removed	6449
@VP	removed	6453
@VP	washed twice with HBSS -LRB- Invitrogen -RRB-	6549
@VP	diced into small fragments	6586
@VP	stopped by adding DMEM/Ham 's	6763
@VP	adding DMEM/Ham 's	6774
@VP	supplemented with 10 % FBS	6824
@VP	dissociated cells	6888
@VP	washed twice	6911
@VP	resuspended in df-10S plus 2 µM forskolin and 20 µg/ml pituitary extract	6925
@VP	then plated onto poly-L-lysine-coated culture dishes	7003
@VP	using a modification of the published protocol	7257
@VP	detached with 0.05 % trypsin and 0.02 % EDTA -LRB- Invitrogen -RRB-	7344
@VP	centrifuged	7401
@VP	washed two times	7414
@VP	resuspended in L-15	7432
@VP	then plated on antibody-treated dishes for 30 min at 4 °C	7457
@VP	washed three times with ice-cold L-15	7690
@VP	finally washed three times with ice-cold L-15 medium	7821
@VP	were removed	7896
@VP	removed	7901
@VP	were washed gently five times with ice-cold L-15 medium	7925
@VP	washed gently five times with ice-cold L-15 medium	7930
@VP	detached from the dishes with 0.05 % trypsin and 0.02 % EDTA	8116
@VP	washed twice with df-10S	8179
@VP	plated onto poly-lysine-coated culture dishes	8303
@VP	allowed to grow to confluency	8350
@VP	to grow to confluency	8358
@VP	grow to confluency	8361
@VP	harvested -LRB- in DMEM/F -12 -RRB- for transplantation	8390
@VP	approved all animal procedures	8706
@VP	was shaved and aseptically prepared with betadine	9000
@VP	shaved	9004
@VP	was administered before surgical procedures were performed	9105
@VP	administered before surgical procedures were performed	9109
@VP	were performed	9149
@VP	performed	9154
@VP	were kept on a heating pad to maintain the body temperature at 37 ± 0.5 °C	9190
@VP	kept on a heating pad to maintain the body temperature at 37 ± 0.5 °C	9195
@VP	to maintain the body temperature at 37 ± 0.5 °C	9217
@VP	maintain the body temperature at 37 ± 0.5 °C	9220
@VP	was induced by the weight drop device	9301
@VP	induced by the weight drop device	9305
@VP	developed at New	9339
@VP	disrupting the dura mater , the ninth thoracic -LRB- T9 -RRB-	9396
@VP	was exposed by removing the dorsal part of the T8 vertebra	9467
@VP	exposed by removing the dorsal part of the T8 vertebra	9471
@VP	removing the dorsal part of the T8 vertebra	9482
@VP	contused by a 10 gm weight that was dropped from a height of 12.5 mm	9564
@VP	was dropped from a height of 12.5 mm	9596
@VP	dropped from a height of 12.5 mm	9600
@VP	were monitored to guarantee consistency between animals	9680
@VP	monitored to guarantee consistency between animals	9685
@VP	to guarantee consistency between animals	9695
@VP	guarantee consistency between animals	9698
@VP	were sutured in layers	9763
@VP	sutured in layers	9768
@VP	was closed	9799
@VP	closed	9803
@VP	were returned to their	9820
@VP	returned to their	9825
@VP	warmed cages with ad libitum access to water and food	9850
@VP	was administered 2 , 4 , and 6 d after the contusion injury	9914
@VP	administered 2 , 4 , and 6 d after the contusion injury	9918
@VP	were maintained for a total of 12 weeks after injury	9982
@VP	maintained for a total of 12 weeks after injury	9987
@VP	exposed	10101
@VP	using a 10 µl Hamilton syringe held in a micromanipulator	10326
@VP	held in a micromanipulator	10357
@VP	were injected with 6 µl of DMEM-F12 medium	10398
@VP	injected with 6 µl of DMEM-F12 medium	10403
@VP	were closed separately	10491
@VP	closed separately	10496
@VP	were randomly divided into subgroups for retrograde and anterograde tracing	10655
@VP	randomly divided into subgroups for retrograde and anterograde tracing	10660
@VP	tracing	10723
@VP	tracing	10751
@VP	tracing	10783
@VP	anesthetized	10863
@VP	biotinylated	10880
@VP	tracing	11294
@VP	was exposed	11356
@VP	exposed	11360
@VP	held in a micromanipulator -LRB- Takami et al. , 2002 -RRB-	11603
@VP	was performed over a 3 min period	11668
@VP	performed over a 3 min period	11672
@VP	was kept in place for an additional 3 min to minimize leakage on withdrawal	11728
@VP	kept in place for an additional 3 min to minimize leakage on withdrawal	11732
@VP	to minimize leakage on withdrawal	11770
@VP	minimize leakage on withdrawal	11773
@VP	were closed in layers	11847
@VP	closed in layers	11852
@VP	included the contusion injury	12179
@VP	were dissected and embedded in gelatin -LRB- Oudega et al. , 1994 -RRB-	12210
@VP	dissected and embedded in gelatin -LRB- Oudega et al. , 1994 -RRB-	12215
@VP	Using a sliding freezing microtome	12272
@VP	were cut into 40 - mthick horizontal sections	12335
@VP	cut into 40 - mthick horizontal sections	12340
@VP	were cut into 40-µm-thick transverse sections	12459
@VP	cut into 40-µm-thick transverse sections	12464
@VP	were collected in PBS -LRB- 0.1 M , pH 7.4 -RRB-	12519
@VP	collected in PBS -LRB- 0.1 M , pH 7.4 -RRB-	12524
@VP	kept at 4 °C until further processing	12561
@VP	was dissected and divided into three 2-mm-long pieces	12704
@VP	dissected and divided into three 2-mm-long pieces	12708
@VP	were prepared for analysis as described previously -LRB- Xu et al. , 1995a -RRB-	12772
@VP	prepared for analysis as described previously -LRB- Xu et al. , 1995a -RRB-	12777
@VP	described previously	12802
@VP	were determined by systematic random sampling -LRB- West , 1993 -RRB-	13067
@VP	determined by systematic random sampling -LRB- West , 1993 -RRB-	13072
@VP	injured	13198
@VP	outlined	13228
@VP	scanned using a fractionator grid , which ranged in size from 35 to 70 µm2	13246
@VP	using a fractionator grid , which ranged in size from 35 to 70 µm2	13254
@VP	ranged in size from 35 to 70 µm2	13287
@VP	used for all counts	13340
@VP	was 100x with oil immersion	13360
@VP	was present	13454
@VP	were counted	13519
@VP	counted	13524
@VP	was analyzed	13586
@VP	analyzed	13590
@VP	is required per lesion -- transplant area	13722
@VP	required per lesion -- transplant area	13725
@VP	contained a very large cavity	13902
@VP	tracing	14148
@VP	tracing	14202
@VP	were examined in every fifth section of the T7 -- 9 cord segments	14243
@VP	examined in every fifth section of the T7 -- 9 cord segments	14248
@VP	summed per rat	14712
@VP	then multiplied by 5 to obtain the final number of labeled corticospinal axons	14731
@VP	to obtain the final number of labeled corticospinal axons	14752
@VP	obtain the final number of labeled corticospinal axons	14755
@VP	mounted onto gelatin-coated glass slides	14872
@VP	containing the nuclear dye , Hoechst -LRB- 100 µM , Sigma -RRB-	14968
@VP	dye , Hoechst -LRB- 100 µM , Sigma -RRB-	14991
@VP	dye	14991
@VP	tracing	15168
@VP	mounted on gelatin-coated glass slides	15229
@VP	coverslipped with Citifluor -LRB- UKC Chemical Laboratory -RRB-	15272
@VP	mounted onto gelatin-coated slides	15473
@VP	coverslipped with Citifluor -LRB- UKC Chemical Laboratory -RRB-	15512
@VP	was determined in each section	15614
@VP	determined in each section	15618
@VP	summed per rat	15665
@VP	to obtain the final number of labeled neurons	15767
@VP	obtain the final number of labeled neurons	15770
@VP	mounted onto gelatin-coated glass slides	15908
@VP	stained with cresyl violet	15950
@VP	dehydrated	15978
@VP	were determined	16320
@VP	determined	16325
@VP	contained small cysts	16559
@VP	summed per rat	16620
@VP	was analyzed	16676
@VP	analyzed	16680
@VP	give the total area of the 5-mm-long cord segment and of damaged spinal tissue	16693
@VP	were then calculated by means of numerical integration	16785
@VP	calculated by means of numerical integration	16795
@VP	subtracting the volume of damaged tissue from the volume of the whole segment	16923
@VP	described	17341
@VP	used	17409
@VP	used	17723
@VP	used	18091
@VP	conjugated goat anti-rabbit -LRB- 1:200 ; Molecular Probes -RRB- and Alexa 594	18112
@VP	conjugated rabbit anti-mouse -LRB- 1:200 ; Molecular Probes -RRB-	18181
@VP	mounted onto gelatin-coated glass slides	18255
@VP	containing 100 µM Hoechst dye -LRB- Sigma -RRB-	18352
@VP	dye	18378
@VP	Open field locomotor test	18391
@VP	developed by Basso et al. -LRB- 1995 , 1996 -RRB-	18489
@VP	received anterograde tracing	18642
@VP	tracing	18663
@VP	followed by Fisher 's protected least-significant difference test	18738
@VP	determined for each group	18900
@VP	followed by Mann	19020
@VP	was used	19053
@VP	used	19057
@VP	score per group were statistically significant	19182
@VP	were statistically significant	19198
@VP	was accepted at p < 0.05	19269
@VP	accepted at p < 0.05	19273
@VP	limit contusion-induced spinal tissue damage	19419
@VP	indicate the contusion impact site	19671
@VP	indicate cystic cavities	19719
@VP	indicate coagulated blood between the dura mater and the spinal cord	19761
@VP	coagulated blood between the dura mater and the spinal cord	19770
@VP	analyzed spinal segment -LRB- T9 cord segment -RRB- in an uninjured spinal cord	20132
@VP	contain numerous myelinated axons in the middle of the graft	20336
@VP	show toluidine blue-stained , 1-µm-thick plastic sections	20409
@VP	indicate cystic cavities	20509
@VP	demonstrating that SCs have migrated into the lesion area	20579
@VP	have migrated into the lesion area	20602
@VP	migrated into the lesion area	20607
@VP	as evidenced by the presence of peripheral-type myelin -LRB- arrows -RRB-	20638
@VP	are present within the SC transplant	20809
@VP	contain more myelinated axons than OEG-only grafts	21138
@VP	are found in the cord near the cavity in a control animal	21247
@VP	found in the cord near the cavity in a control animal	21251
@VP	showing that host SCs	21306
@VP	migrated into the spinal cord as well as into the lesion site	21328
@VP	grafting of SCs	21400
@VP	were observed in the lesion area at 12 weeks	21446
@VP	observed in the lesion area at 12 weeks	21451
@VP	were typically ensheathed by nonmyelinating SCs	21543
@VP	ensheathed by nonmyelinating SCs	21558
@VP	was evident	21704
@VP	only meandering -LRB- arrows -RRB-	21803
@VP	clearly ensheathing processes extended from the cells	21840
@VP	extended from the cells	21870
@VP	indicating that these cells were not oligodendrocytes	21951
@VP	were not oligodendrocytes	21979
@VP	show electron micrographs	22017
@VP	Transplanted glia	22088
@VP	survive , express CSPG , and promote sparing/regeneration of axons	22106
@VP	survive , express CSPG	22106
@VP	promote sparing/regeneration of axons	22133
@VP	taken from horizontal sections of the T9 cord segment 3 months after injury	22200
@VP	is shown in medium - -LRB- A -RRB- , SC - -LRB- B -RRB-	22312
@VP	shown in medium - -LRB- A -RRB- , SC - -LRB- B -RRB-	22315
@VP	injected animals	22359
@VP	indicate the transplants	22653
@VP	are higher magnifications of the boxed areas in D , E , and F , respectively	22775
@VP	boxed areas in D , E , and F , respectively	22808
@VP	was more intense in SC-containing grafts than in OEG-only grafts	22875
@VP	was most intense in the SC graft	23026
@VP	receiving SC-containing grafts	23127
@VP	contained many neurofilament-positive axons as demonstrated in M , an SC graft	23175
@VP	demonstrated in M , an SC graft	23222
@VP	were CGRP positive as shown in an SC transplant -LRB- N -RRB-	23290
@VP	shown in an SC transplant -LRB- N -RRB-	23312
@VP	penetrating the transplant -LRB- arrows -RRB-	23437
@VP	containing Schwann cells	23601
@VP	promote the most sparing/regeneration of propriospinal and supraspinal axons	23758
@VP	were present in the T8	23855
@VP	injected animals	23920
@VP	injected animals	24122
@VP	injected animals	24294
@VP	promote corticospinal axon sparing/regeneration	24693
@VP	taken from horizontal 40 - m-thick sections	24779
@VP	outlined	24880
@VP	indicate a significant difference of p < 0.01 from controls	25123
@VP	improves hindlimb performance	25540
@VP	shows the average open-field BBB score at different times after injury	25581
@VP	was evaluated blindly once a week for 11 weeks	25689
@VP	evaluated blindly once a week for 11 weeks	25693
@VP	are presented as means ± SEM	25742
@VP	presented as means ± SEM	25746
@VP	± SEM	25765
@VP	had a significantly higher BBB score at 8 -- 11 weeks after grafting	25936
@VP	grafting	25993
@VP	grafting	26092
@VP	were present extending in the rostral -- caudal direction -LRB- Fig. 1A -RRB-	26233
@VP	extending in the rostral -- caudal direction -LRB- Fig. 1A -RRB-	26246
@VP	were widest at the lesion epicenter	26311
@VP	could be observed -LRB- Fig. 1C , D -RRB-	26472
@VP	be observed -LRB- Fig. 1C , D -RRB-	26478
@VP	observed -LRB- Fig. 1C , D -RRB-	26481
@VP	was 21.2 ± 0.9 mm3 -LRB- SEM ; n = 4 -RRB-	26961
@VP	Grafting the combination of SCs and OEG	27491
@VP	resulted in a volume of 9.4	27531
@VP	promotes spinal tissue sparing	27875
@VP	to examine the presence of myelinated axons within and around the transplants	28094
@VP	examine the presence of myelinated axons within and around the transplants	28097
@VP	was found within the large cavities -LRB- Fig. 2A -RRB-	28229
@VP	found within the large cavities -LRB- Fig. 2A -RRB-	28233
@VP	surrounded by typical peripheral-type -LRB- SC -RRB- myelin -LRB- Fig. 2B -RRB-	28304
@VP	to recognize peripheral-type myelin in plastic cross sections	28378
@VP	recognize peripheral-type myelin in plastic cross sections	28381
@VP	caused by the formation of extracellular matrix -LRB- Bunge et al. , 1994 -RRB-	28598
@VP	do not exhibit adjacent nuclei and have little or no space between them	28710
@VP	do not exhibit adjacent nuclei	28710
@VP	exhibit adjacent nuclei	28717
@VP	have little or no space between them	28745
@VP	grafted animals	28809
@VP	contained axons with typical central-type -LRB- oligodendrocyte -RRB- myelin	28870
@VP	was observed	28937
@VP	observed	28941
@VP	had migrated from the dorsal roots into the damaged spinal cord	29077
@VP	migrated from the dorsal roots into the damaged spinal cord	29081
@VP	contained axons surrounded by peripheraltype myelin -LRB- Fig. 2B , D , F -RRB-	29162
@VP	surrounded by peripheraltype myelin -LRB- Fig. 2B , D , F -RRB-	29178
@VP	compare D , F ; Table 1	29320
@VP	was similar in all groups -LRB- Table 1 -RRB-	30086
@VP	run parallel to the myelin sheath	30281
@VP	does not exhibit these features	30336
@VP	exhibit these features	30345
@VP	illustrates central - and peripheral-type myelin in tissue next to a cavity	30406
@VP	is little glial limiting membrane evident , in other areas	30532
@VP	limiting membrane evident , in other areas	30548
@VP	was much more prominent at the interface between central tissue and invading SCs	30593
@VP	invading SCs	30661
@VP	was observed also in grafted animals	30784
@VP	observed also in grafted animals	30788
@VP	were not evident in the SC area in Figure 3A	30862
@VP	examined	30923
@VP	was only minimally developed at 12 weeks	30945
@VP	minimally developed at 12 weeks	30954
@VP	are prominent	31140
@VP	were often clustered around blood vessels	31193
@VP	clustered around blood vessels	31204
@VP	were seen in all samples	31259
@VP	seen in all samples	31264
@VP	was observed , suggestive of remyelination by oligodendrocytes	31336
@VP	was observed	31336
@VP	observed	31340
@VP	suggestive of remyelination by oligodendrocytes	31350
@VP	were present	31574
@VP	were surrounded by basal lamina	31600
@VP	surrounded by basal lamina	31605
@VP	varied considerably in diameter	31639
@VP	was of the peripheral type	31737
@VP	was not possible to identify the OEG	31809
@VP	to identify the OEG	31826
@VP	identify the OEG	31829
@VP	to determine whether the myelin had been formed by OEG or host SCs	31930
@VP	determine whether the myelin had been formed by OEG or host SCs	31933
@VP	had been formed by OEG or host SCs	31962
@VP	been formed by OEG or host SCs	31966
@VP	formed by OEG or host SCs	31971
@VP	considered likely to be OEG	32045
@VP	to be OEG	32063
@VP	be OEG	32066
@VP	were observed	32073
@VP	observed	32078
@VP	exhibited patches of basal lamina	32093
@VP	meandered among clusters of axons but did not encircle them as SCs do	32155
@VP	meandered among clusters of axons	32155
@VP	did not encircle them as SCs do	32193
@VP	encircle them as SCs do	32201
@VP	do	32222
@VP	found only in an area of central myelinated axons near the site of implantation	32253
@VP	were not seen in SC-only grafts	32337
@VP	seen in SC-only grafts	32346
@VP	Transplanted glia	32370
@VP	survive and support axonal sparing/regeneration	32388
@VP	was found in strands of tissue within the damaged area -LRB- Fig. 4A -RRB-	32620
@VP	found in strands of tissue within the damaged area -LRB- Fig. 4A -RRB-	32624
@VP	was observed within the transplanted area	32772
@VP	observed within the transplanted area	32776
@VP	appeared more intense and extensive in SC grafts than in OEG or SC/OEG grafts	32843
@VP	was evaluated using antibodies against GFAP	32995
@VP	evaluated using antibodies against GFAP	32999
@VP	using antibodies against GFAP	33009
@VP	delineated the injury area	33124
@VP	surrounding the SC -LRB- Fig. 4D -RRB-	33213
@VP	was found within the transplants	33308
@VP	found within the transplants	33312
@VP	was studied using the CS-56 antibody	33539
@VP	studied using the CS-56 antibody	33543
@VP	using the CS-56 antibody	33551
@VP	was found within the injury area	33616
@VP	found within the injury area	33620
@VP	displayed CSPG immunoreactivity	33716
@VP	indicating the presence of numerous axons	33929
@VP	were used to examine phenotypes of these axons	34064
@VP	used to examine phenotypes of these axons	34069
@VP	to examine phenotypes of these axons	34074
@VP	examine phenotypes of these axons	34077
@VP	ascending sensory axons -LRB- Gibson et al. , 1984 -RRB-	34147
@VP	had grown into and across , but not beyond , the grafts -LRB- Fig. 4N -RRB-	34193
@VP	grown into and across , but not beyond , the grafts -LRB- Fig. 4N -RRB-	34197
@VP	were also found within the surrounding white matter	34278
@VP	found within the surrounding white matter	34288
@VP	had grown into the grafts -LRB- Fig. 4O -RRB-	34457
@VP	grown into the grafts -LRB- Fig. 4O -RRB-	34461
@VP	originating from locus ceruleus neurons	34632
@VP	identified with anti-D Hantibodies -LRB- Newton and Hamill , 1988 -RRB-	34676
@VP	indicate that the transplants contain some sensory and serotonergic axons	34850
@VP	contain some sensory and serotonergic axons	34880
@VP	appear to originate from spinal cord neurons	34947
@VP	to originate from spinal cord neurons	34954
@VP	originate from spinal cord neurons	34957
@VP	was examined using retrograde FB neuronal tracing	35185
@VP	examined using retrograde FB neuronal tracing	35189
@VP	using retrograde FB neuronal tracing	35198
@VP	tracing	35227
@VP	receiving SC or SC/OEG	35836
@VP	found within the cerebral cortex of control -LRB- Fig. 5G -RRB-	35952
@VP	grafted -LRB- Fig. 5H -RRB- animals	36010
@VP	placed within a 1 week moderately contused thoracic spinal cord	36216
@VP	moderately contused thoracic spinal cord	36239
@VP	promote the sparing / regeneration of propriospinal and supraspinal axons	36280
@VP	appeared by this measure to affect sparing/regeneration of corticospinal axons	36373
@VP	to affect sparing/regeneration of corticospinal axons	36398
@VP	affect sparing/regeneration of corticospinal axons	36401
@VP	tracing analysis The presence of corticospinal axons in the grafted area	36472
@VP	was evaluated using anterograde axonal tracing	36545
@VP	evaluated using anterograde axonal tracing	36549
@VP	using anterograde axonal tracing	36559
@VP	tracing	36584
@VP	were present rostral to the grafted area	36651
@VP	indicating ongoing degeneration -LRB- Tator , 1995 -RRB-	36725
@VP	found at 1 mm rostral to the epicenter and at the epicenter	37105
@VP	did not significantly differ between groups -LRB- Fig. 6B -RRB-	37165
@VP	significantly differ between groups -LRB- Fig. 6B -RRB-	37173
@VP	was examined using anterograde axonal tracing	37293
@VP	examined using anterograde axonal tracing	37297
@VP	using anterograde axonal tracing	37306
@VP	tracing	37331
@VP	were observed in the peripheral spinal white matter but rarely in the grafts	37430
@VP	observed in the peripheral spinal white matter but rarely in the grafts	37435
@VP	recovered to a BBB score of 10 -- 11	37778
@VP	stepping	37900
@VP	stepping with occasional to frequent forelimb -- hindlimb	37958
@VP	was observed only in SC-only grafted animals	38044
@VP	observed only in SC-only grafted animals	38048
@VP	were significantly higher -LRB- p < 0.05 -RRB- than the control group	38263
@VP	see Bunge , 2001 ; Plant et al. , 2001 -RRB- and OEG	38393
@VP	have been studied in different adult rat spinal cord injury models	38564
@VP	been studied in different adult rat spinal cord injury models	38569
@VP	studied in different adult rat spinal cord injury models	38574
@VP	investigated	38646
@VP	grafted into a 1-week-old moderate contusion lesion in the adult rat	38724
@VP	diminished injury-induced cavitation	38851
@VP	indicate that a SC graft is more effective in promoting spinal tissue sparing	38901
@VP	is more effective in promoting spinal tissue sparing	38926
@VP	promoting spinal tissue sparing	38947
@VP	promoting sparing/regeneration of spinal and supraspinal axons than an OEG graft	39026
@VP	promoted axonal growth	39119
@VP	exhibited the greatest number of myelinated axons	39157
@VP	was significantly improved 8 weeks after transplantation	39304
@VP	improved 8 weeks after transplantation	39322
@VP	tracing	39382
@VP	demonstrated that with SC and SC/OEG grafts	39390
@VP	promoted axonal sparing	39571
@VP	reduced injury-induced axonal dieback , or axonal regeneration ,	39602
@VP	had been injected 1 week after injury	39782
@VP	been injected 1 week after injury	39786
@VP	injected 1 week after injury	39791
@VP	obliterates the corticospinal tract -LRB- Hill et al. , 2001 -RRB-	39864
@VP	could be sprouting from spared lateral and ventral corticospinal fibers	40026
@VP	be sprouting from spared lateral and ventral corticospinal fibers	40032
@VP	sprouting from spared lateral and ventral corticospinal fibers	40035
@VP	spared lateral and ventral corticospinal fibers	40050
@VP	were found to promote spinal tissue sparing at 12 weeks after injury	40127
@VP	found to promote spinal tissue sparing at 12 weeks after injury	40132
@VP	to promote spinal tissue sparing at 12 weeks after injury	40138
@VP	promote spinal tissue sparing at 12 weeks after injury	40141
@VP	sparing at 12 weeks after injury	40163
@VP	reducing spinal tissue damage than the SC/OEG or OEG-only graft	40242
@VP	are believed to be a distinct cell type -LRB- Lakatos et al. , 2000 -RRB-	40870
@VP	believed to be a distinct cell type -LRB- Lakatos et al. , 2000 -RRB-	40874
@VP	to be a distinct cell type -LRB- Lakatos et al. , 2000 -RRB-	40883
@VP	be a distinct cell type -LRB- Lakatos et al. , 2000 -RRB-	40886
@VP	harvested from the adult olfactory bulb	40975
@VP	produce neurotrophic factors	41015
@VP	have differed on the production of neurotrophic factors by OEG	41130
@VP	differed on the production of neurotrophic factors by OEG	41135
@VP	see Kleitman and Bunge , 2000	41206
@VP	may have caused the observed difference in tissue sparing	41458
@VP	have caused the observed difference in tissue sparing	41462
@VP	caused the observed difference in tissue sparing	41467
@VP	filled with an SC graft -LRB- Ramo ' n-Cueto et al. , 1998 -RRB-	42146
@VP	were found to cross the injury site and grow into the spinal cord	42205
@VP	found to cross the injury site and grow into the spinal cord	42210
@VP	to cross the injury site and grow into the spinal cord	42216
@VP	cross the injury site and grow into the spinal cord	42219
@VP	cross the injury site	42219
@VP	grow into the spinal cord	42245
@VP	to migrate away from the injury site into the spinal nervous tissue	42322
@VP	migrate away from the injury site into the spinal nervous tissue	42325
@VP	were injected into a 1 week moderate contusion injury	42525
@VP	injected into a 1 week moderate contusion injury	42530
@VP	may be harmful to the grafted cells	42641
@VP	be harmful to the grafted cells	42645
@VP	may have been more susceptible to these cytotoxic events than SCs	42921
@VP	have been more susceptible to these cytotoxic events than SCs	42925
@VP	been more susceptible to these cytotoxic events than SCs	42930
@VP	definitively identifying OEG without a specific label	43083
@VP	are stained by p75 antibody	43155
@VP	stained by p75 antibody	43159
@VP	remyelinate axons in demyelinated cord -LRB- Imaizumi et al. , 1998 , 2000 -RRB-	43241
@VP	demyelinated cord -LRB- Imaizumi et al. , 1998 , 2000 -RRB-	43262
@VP	observed in the electron microscope	43429
@VP	were generally in better continuity with the spinal tissue than OEG transplants	43507
@VP	limiting injury-induced tissue damage	43661
@VP	promoting axonal sparing/regeneration	43703
@VP	forming more myelin than an OEG transplant	43749
@VP	kept in mind that the SC graft contained twice as many SCs as the SC/OEG graft	43812
@VP	contained twice as many SCs as the SC/OEG graft	43843
@VP	were myelinated by SCs or OEG	43990
@VP	myelinated by SCs or OEG	43995
@VP	conducted in our laboratory	44145
@VP	showing that SCs migrate into lesion areas and myelinate axons there	44192
@VP	migrate into lesion areas and myelinate axons there	44209
@VP	located in areas of central-type myelin near the implantation site	44291
@VP	exhibited patches of basal lamina	44358
@VP	meandered among clusters of axons but did not encircle them as SCs typically do	44420
@VP	meandered among clusters of axons	44420
@VP	did not encircle them as SCs typically do	44458
@VP	encircle them as SCs typically do	44466
@VP	do	44497
@VP	see Kleitman and Bunge , 2000	44593
@VP	are OEG that migrated into spinal tissue	44646
@VP	migrated into spinal tissue	44659
@VP	had damaged them	44972
@VP	damaged them	44976
@VP	is needed to prove the ability of OEG to produce myelin	45261
@VP	needed to prove the ability of OEG to produce myelin	45264
@VP	to prove the ability of OEG to produce myelin	45271
@VP	prove the ability of OEG to produce myelin	45274
@VP	to produce myelin	45299
@VP	produce myelin	45302
@VP	improved hindlimb function	45353
@VP	was the only group consistently statistically greater than controls	45403
@VP	reaching spinal segments distal to the grafted area compared with OEG grafts	45597
@VP	seen in the present study	46287
@VP	could explain the observed improvement in functional recovery	46313
@VP	explain the observed improvement in functional recovery	46319
@VP	seen in rats transplanted with embryonic stem cells	46580
@VP	transplanted with embryonic stem cells	46593
@VP	deriving from the grafted stem cells -LRB- McDonald et al. , 1999 -RRB-	46689
@VP	to address this question because the transplanted cells were not prelabeled	46793
@VP	address this question because the transplanted cells were not prelabeled	46796
@VP	were not prelabeled	46849
@VP	prelabeled	46858
@VP	had been prelabeled	46888
@VP	been prelabeled	46892
@VP	prelabeled	46897
@VP	have been possible to identify the myelinated axon as spared or regenerated	46922
@VP	been possible to identify the myelinated axon as spared or regenerated	46927
@VP	to identify the myelinated axon	46941
@VP	identify the myelinated axon	46944
@VP	spared or regenerated	46976
@VP	compared these cell types individually and in combination	47225
@VP	have the greatest effect on protecting contused spinal tissue	47308
@VP	protecting contused spinal tissue	47336
@VP	injured person 's peripheral nerve	47456
@VP	might allow autologous transplantation into the injured human cord	47543
@VP	allow autologous transplantation into the injured human cord	47549
@VP	is necessary for reestablishing axonal circuits that are involved in locomotion	47720
@VP	reestablishing axonal circuits that are involved in locomotion	47737
@VP	are involved in locomotion	47773
@VP	involved in locomotion	47777
@VP	have shown promise in improving such reentry	47805
@VP	shown promise in improving such reentry	47810
@VP	improving such reentry	47827
@VP	promoting axonal growth and myelination than SCs	47903
@VP	transplanted into the contusion lesion	47957
@VP	take advantage of the regenerationpromoting characteristics of both cell types	48032
@VP	is to graft SC into the contusion lesion and OEG into the adjacent spinal tissue	48111
@VP	promoting axonal regeneration/sparing and improving hindlimb function	48249
@VP	promoting axonal regeneration/sparing	48249
@VP	improving hindlimb function	48291
@VP	is currently being investigated in our laboratory	48319
@VP	being investigated in our laboratory	48332
@VP	investigated in our laboratory	48338
